This event discusses how targeted switching of prescription only medicines to non-prescription medicines (Over The Counter medicines) can contribute to self-care of a nation’s population. Availability of diagnostics in the pharmacy and beyond can also make an impact on self-care.

Aim: To discuss which medicines are appropriate to switch from prescription-only to non-prescription (Over The Counter Medicines) and describe how diagnostics can support self-care.

Learning objectives:
1. Describe current approaches to switching medicines from prescription to non-prescription and how this supports self-care ;
2. Discuss which medicines should be available over the counter in the pharmacy;
3. Explain how diagnostics can support self-care.

Moderator:
- Jaime Acosta-Gómez, Community Pharmacist and pharmacy owner, Farmacia Acosta, Spain

Panelists:
- Natalie Gauld, Innovator in improving access to medicines Northern Regional Alliance, University of Auckland, New Zealand
- Andi Shirtcliffe, Clinical Chief Advisor for Pharmacy and Allied Health Ministry of Health New Zealand, New Zealand
- Anthony Serracino Inglott, Professor at the Department of Pharmacy Faculty of Medicine and Surgery, University of Malta, Malta

Summary

Pharmacy teams are increasingly supporting children and their carers with self-care. This webinar will focus particularly on appropriate management of choices of medicines and products to support children’s health, and the role of the pharmacist. A case study will be presented and the event will conclude with a panel discussion.

Aim: To identify how the community pharmacy team can support self-care of common health problems for children and their carers.

Learning objectives: 

1. Increase awareness of children’s health issues, how common they are, what impacts they have and how they can be managed;
2. Learn how to support carers and children with common health issues;
3. Discuss appropriate management in the choice of medicines and products.
4. Describe the role that pharmacist and their team can play in advising and educating carers and children so they can self-care.

Moderator:

• Sarah Dineen-Griffin, Lecturer in health services management and leadership, Charles Sturt University, Australia

Panellist:

• Hadi Dassouki, Community Pharmacist, Lebanon
• Jack Collins, Postdoctoral Research Associate, The University of Sydney School of Pharmacy, Australia
• Joanne Crook, Consultant Pharmacist Paediatrics, Kings College Hospital, UK

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

This programme is all about engaging the profession and supporting the profession to deliver in relevant and purposeful ways. By engaging our profession, members & colleagues everywhere with these relevant and applicable goals for the decade ahead, we can provide tools, monitoring and evaluation through data evidence, and identifying priorities across practice, science, and workforce & education.

Find out more about the FIP Development Goals here: www.fip.org/fip-development-goals

The Global Advanced development framework (GADF) was developed to support the professional development and recognition of the pharmacy workforce everywhere and the Global Competency Framework (GbCF) was developed by the FIP as a focused support structure for early career pharmacists.  This digital event seeks to create more awareness for the GADF and GbCF and to enable early career pharmacists and pharmaceutical scientists have a better understanding of their structure.

Competency framework- A complete collection of competencies that are thought to be essential to performance.

Competencies – Knowledge, skills, behaviors and attitudes that individuals accumulate, develops, and acquires through the education, training and work experience.

Learning objectives:

• Describe the purpose and applications of both the Global Advanced Development Framework (GADF) and the Global competency framework (GbCF);
• Summarize the domains and illustrative competencies from the GbCF for pharmaceutical services (scientific knowledge and management knowledge)
• Identify an individual learning plan based on their learning needs obtained from the self-assessment of GbCF;
• Discuss approach to building a professional practice portfolio.

Moderator:

• Ayodeji Matuluko, Remote Volunteer, FIP Commission on AMR, PhD Candidate, Glasgow Caledonian University, Nigeria

In October-2021, FIP-UNITWIN Regional Workshops brought FIP’s member academic institutions, professional organisations, key pharmacy stakeholders and guests across all regions together to co-create a roadmap to advance pharmacy and pharmaceutical sciences in their region through educational partnerships. At the FIP-UNITWIN Global Summit on pharmaceutical education, participants will.

Learning objectives:
1. Learn about their regions’ roadmap on advancing pharmacy and pharmaceutical sciences education;
2. Explore FIP’s global call to action on pharmaceutical education to support it across their regions and countries;
3. Discover country cases and next steps of the FIP-UNITWIN Centres for Excellence programme

Chairs:

• Catherine Duggan, FIP CEO
• Ralph J. Altiere, FIPEd Chair

Speakers:

• Dominique Jordan, FIP President
• Luis Lorenco, FIP Professional Secretary
• Giovanni Pauletti, FIP Scientific Secretary
• Pierre Moreau, FIP AIM Chair

Panellists:

• Anne Anderson Vice Chair, UK National Commission for UNESCO
• Toyin Tofade, President-Elect of the FIP Academic Pharmacy Section (AcPS) & FIP AIM Advisory Committee Member
• Silvana Nair Leite, FIP AIM Advisory Committee member
• Lilian Azzopardi, AIM Advisory Committee member
• Aukje Mantel-Teeuwisse,FIP Digital Health in Pharmacy Education Report Chair, FIP Technology Forum Member, FIP APS Executive Committee Member
• Beom-Jin Lee, AIM Advisory Committee member
• Rajani Shakya, AIM Advisory Committee member
• Mohamad Rahal, AIM Advisory Committee member
• Rula Darwish, Academic Pharmacy Section Exco
• Paul J. Gallagher, AIM Advisory Committee member
• Mwila Chiluba, AIM Advisory Committee member
• Yahya Choonara, AIM Advisory Committee member
• Arinola Joda, Asst. Secretary/Editor in Chief, APF

Facilitators:

• Nilhan Uzman, FIP Lead for education policy and implementation
• Ozge Ozer, FIP Educational Partnership Coordinator
• Alison Ubong Etukakpan, FIP Educational Partnership Coordinator

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them. The 20^th episode of the Programme focuses on FIP Development Goal 14: Medicines Expertise. The details of the Goal are available here: https://www.fip.org/fip-development-goal-14

The expected outcomes of the event are:

1. Describe the FIP Development Goals and explain the components of DG 14 (and its three elements: workforce & education, science and practice).
2. Showcase the FIP tools, evidence, and resources to support DG 14 implementation across the three elements.
3. Identify priorities across practice, science, and workforce & education within DG 14
4. Discuss the importance monitoring and evaluation through data evidence and engage participants with FIP indicators development project

Moderator:

• Dalia Bajis, FIP Lead for Provision and Partnership, Bahrain 

Panellist:

• Hala Fadda, Chair of FIP Pediatric Formulations Focus Group, Associate Professor, College of Pharmacy and Health Sciences Buter University, USA
• Sham Moodley, Pharmacist, FIP CPS Exco Member, Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc (ICPA), South Africa

Summary
There is variability across the globe in the provision of universal healthcare. Self-care is the ability to maintain and improve individual’s health, prevent or limit diagnosed illnesses, and address self-treatable conditions. Self care is not no care and it is not necessarily practised in isolation. It may involve support and advice from others, such as expert pharmacy teams.  This event discusses how self-care can contribute to Universal Health Coverage from the perspectives of providers of healthcare services and public and patients. 

Aim: To discuss the perspectives of providers of healthcare services and the people accessing them about how self-care can contribute to universal health coverage.

Learning objectives: 

• Explain the extent to which self-care is embedded in healthcare systems;
• Discuss cultural approaches to enabling self-care as part of UHC, such as healthy lifestyles;
• List healthcare systems and patients/public’s needs for enabling self-care;
• Discuss the contribution of localised self-care delivery to UHC

Moderator:

• Sham Moodley, Community Pharmacist, Member of the FIP Community Pharmacy Section, South Africa

Panellist:

• K Srinath Reddy, President, Public Health Foundation of India, India
  
• Jacqueline Bowman-Busato, Co-Founder, Belgian Private Foundation Pate Adiposité Adipositas Pacte, Belgium
• Dave Burrows, CEO and CTO, Damibu, UK

Traditionally, the distribution of medicines to consumers has been organized through heavily regulated networks of physical pharmacies. The strict regulation of market structure has been in place to ensure the safety, accessibility and affordability of medicines, but it has also limited competition in the pharmacy sector. Nowadays, the regulation of pharmacies differs between countries, and this has created different market conditions for online pharmacies to operate.

In some countries the online sales of medicines have grown considerably during the recent years as consumers have become more accustomed to e-commerce. More lately the Covid-19 pandemic has dramatically shaped the e-commerce landscape. Due to the pandemic, the demand for online services of pharmacies has increased significantly in many countries. It is also likely that this has changed preferences for some consumers permanently and demand should therefore remain at a higher level in the future.

Increased cooperation between countries in developing regulation of online pharmacies is needed, according to the report, “Online pharmacy operations and distribution of medicines”, which will be published by the International Pharmaceutical Federation (FIP) on December 8th, 2021.

Moderator:

• Lars-Åke Söderlund, FIP Vice President, Executive Advisor, Apoteket AB, Sweden, Sweden

Co-Moderator:

• Sarah Dineen-Griffin, Lecturer, Health Service Management, Charles Stuart University, Australia

Panellist:

• Catherine Duggan, FIP CEO, The Netherlands
• Manjiri Gharat, Principal, K. M. Kundnani Pharmacy Polytechnic, India
  
• Sari Westermarck, Community pharmacist, Finland
  
• Jacqueline Surugue, Immediate Past Vice President FIP, France
• Nadia Al Mazrouei, Assistant Professor, Sharjah University, United Arab Emirates (UAE) 
• Jorge Schlottke, Pharmacist, Centro Oncológico Integral de la Provincia de San Luis, Argentina
• John Jackson, President, Western Pacific Pharmaceutical Forum, Australia  
• Prosper Hiag, President, African Pharmaceutical Forum, Cameroon
• Jaime Acosta-Gómez, Community Pharmacist and pharmacy owner, Farmacia Acosta, Spain

Summary:

Gastrointestinal symptoms have an impact on the health and wellbeing of individuals that can be debilitating, however, the majority of people can be supported by the pharmacy team to self-care and effectively manage their symptoms.

Aim: 

To explore: lifestyle factors that can cause or worsen gastrointestinal complaints and the role of pharmacy team in supporting the majority of customers to self-care and effectively manage their symptoms.

Learning objectives: 

1. List common GI symptoms and their impact on people;
2. Identify and suggest approaches to addressing lifestyle factors causing GI symptoms.
3. Discuss the role of pharmacy team to support people with GI symptoms to self-care

Moderator:
- Manjiri Gharat, FIP Vice-President, India

Panellists:
- Ruth Rudling, Advanced Clinical Pharmacist for Specialty Medicines, Mid Yorkshire NHS Trust (MYHT), UK
- Anja St. Clair-Jones, Consultant Pharmacist Gastroenterology, University Hospitals Sussex, UK

At this event on World AIDS day, we will explore the different roles pharmacists can have in the prevention and screening of HIV infections, as well as in providing care and support to people living with HIV, namely through medication management. Other roles for pharmacists include HIV prevention through dispensing and providing support to preexposure prophylaxis (PrEP), HIV testing and harm reduction strategies for IV drugs users.

The World Health Organization estimates that around 38 million people live with HIV globally. Although there is still no cure for HIV, with the advancement of therapies and increasing access to effective HIV prevention, diagnosis, treatment and care, including for opportunistic infections, HIV infection has become a manageable chronic health condition, enabling people living with HIV to lead long and healthy lives.

Learning objectives:
1. Describe the burden and characteristics of HIV globally.
2. Understand the possibilities of involvement of pharmacists in the clinical care of people living with HIV.
3. Describe the role of pharmacists in PrEP-related services.

Moderator:
- Victoria Garcia Cardenas, FIP Pharmacy Practice Research SIG, Chair Senior Lecturer University of Technology Sydney, Australia / Spain

Panelists:
- Sham Moodley, FIP CPS Exco Member, Pharmacist Pharmaceutical Society of South Africa/Independent Community Pharmacy Assoc (ICPA), South Africa
- Nelli Barrière, Project Manager, HIV Programmes and Advocacy International AIDS Society, Switzerland
- Pilar Taberner Bonastre, Hospital pharmacist, Hospital Universitario Arnau de Vilanova, Lleida Spain
- Katrina F. Ortblad, Assistant Professor Fred Hutchinson Cancer Research Center, United States of America
- Tessa Oraro-Lawrence, Project Manager, HIV Programmes and Advocacy International AIDS Society, Switzerland

Para abogar por una implementación más amplia y armonizada de bioexenciones basadas en el sistema de clasificación biofarmacéutica (BCS) en los países de América Latina, la FIP está apoyando a los líderes regionales en la sensibilización sobre esta vía reguladora basada en la ciencia diseñada para acelerar la aprobación del mercado de productos farmacéuticos genéricos seguros y eficaces. La segunda parte de esta serie de seminarios web diseñados específicamente para la región de América Latina destaca ejemplos de vías de aprobación regulatoria de bioexenciones basadas en BCS que se implementan actualmente en países seleccionados de América Latina. Los expertos abordarán la base legislativa de las regulaciones de bioexenciones y discutirán las oportunidades de armonización dentro de la región.

Este webinar tiene los objetivos:

• Diferenciar entre la bioequivalencia in vivo y las estrategias reguladoras de bioexención basadas en BCS para la aprobación de medicamentos genéricos.
• Comprender las implicaciones para la salud pública de la vía reguladora de la bioexención basada en BCS.
• Delinear oportunidades y desafíos para la implementación de un proceso armonizado de aprobación regulatoria de bioexenciones dentro de la región de América Latina.
• Delinear las contribuciones de solubilidad, permeabilidad y disolución para aplicaciones de bioexención basadas en BCS.

Moderadora:
-Talita Ferreira, Coordinadora de Proyectos de bioexención en Latinoamérica FIP

Panelistas:
-Alfredo García Arieta, Jefe del Servicio de Farmacocinética y Medicamentos Genéricos AEMPS
-Andrés Figueroa Campos, Gerente SD Registro Sanitario de Productos Farmacéuticos Bioequivalentes
ANAMED ISPch–Agencia Nacional de Vigilancia Sanitaria de Chile
-Jorge Iliou, Dirección NVVS de Paraguay
-Alexis Aceituno,Jefe SD Registro Sanitario de Productos Farmacéuticos Bioequivalentes ANAMED ISPch–ANVSChile
-Miguel Angel Cabrera Prof. Asociado Central University of Las Villas

The global session entitled  ‘Accelerating AMR Action Through Antimicrobial Stewardship:  Are pharmacists the protagonists in the fight against antibiotic resistance?’ takes a debate format with 2 teams of three, protagonists and antagonists, speaking to a case study or personal experience to highlight good (protagonist) or bad (antagonist) practice that reflects the reality of the challenges faced by pharmacy in tackling AMR, with a particular focus on low to middle income countries

Moderators:
- Sabiha Essack
- Manjiri Gharat

Welcome and Objectives:
- Introducing FIP AMR Commission and goals of GRIP partnership; overview of 2020 -2021 roadmap progress
Panel Discussion:
- ‘Are pharmacists the protagonists in the fight against antibiotic resistance?’
Using case studies to highlight best practice, as well as bad practice, to reflect the reality of the challenges faced by pharmacy in tackling AMR, with a particular focus in low to middle income countries

Regional Highlights:
- Highlights of the regional ideas that delivered most change/progress towards the AMR roadmap developed in our FIP Virtual 2020 events

Next steps and close:
- Next steps and role of the AMR Commission; renewed commitment to AMR going forward

In 2020, Reckitt and the Global Respiratory Infection Partnership (GRIP) partnered with FIP to host a series of events combining efforts with the ambition of “Driving AMR action in a new decade”. One global event and six regional workshops were held, with over 4,000 participants engaging in collaborative efforts to identify and implement region-specific initiatives to mitigate AMR. The success of this partnership culminated in the FIP Regional AMR Roadmaps which identified regional initiatives to drive behaviour change and aid in the global fight against AMR.

This year GRIP, FIP and Reckitt continue to share this global commitment as we partner to bring you a series of events aimed at further driving a collaborative approach to AMR mitigation for pharmacy. Co-chaired by regional representatives from FIP and GRIP, we will aim to showcase the progress in the AMR Roadmap made in the South East Asian Region over the past 12 months.

Moderators:
- Manjiri Gharat
- Wirat Tongord

Welcome and Objectives:
- Introducing regional leads and recap of ambitions of the Pharmacy AMR Roadmap

Panel Discussion:
- ‘AMR Stewardship in Action’
Regional leads to moderate a panel discussion on a total of 3 good and bad practice case studies from submissions and/or initiatives they have identified. Where possible, those involved in good practice initiatives will be invited to join the panel discussion.

AMR ACCELERATOR:
- Audience can interact with good practice initiatives, ‘accelerating’ the idea in their country by making a commitment to adopt or support the initiative.

Thank you and close:
- The AMR accelerator idea with the most traction is presented during the global session.

In 2020, Reckitt and the Global Respiratory Infection Partnership (GRIP) partnered with FIP to host a series of events combining efforts with the ambition of “Driving AMR action in a new decade”. One global event and six regional workshops were held, with over 4,000 participants engaging in collaborative efforts to identify and implement region-specific initiatives to mitigate AMR. The success of this partnership culminated in the FIP Regional AMR Roadmaps which identified regional initiatives to drive behaviour change and aid in the global fight against AMR.

This year GRIP, FIP and Reckitt continue to share this global commitment as we partner to bring you a series of events aimed at further driving a collaborative approach to AMR mitigation for pharmacy. Co-chaired by regional representatives from FIP and GRIP, we will aim to showcase the progress in the AMR Roadmap made in the Eastern Mediterranean Region over the past 12 months.

Moderators:
- Dalal Hammoudi,
- Khalid Eljaaly
- Nada Ahmed

Welcome and Objectives:
- Introducing regional leads and recap of ambitions of the Pharmacy AMR Roadmap

Panel Discussion:
- ‘AMR Stewardship in Action’
Regional leads to moderate a panel discussion on a total of 3 good and bad practice case studies from submissions and/or initiatives they have identified. Where possible, those involved in good practice initiatives will be invited to join the panel discussion.

AMR ACCELERATOR:
- Audience can interact with good practice initiatives, ‘accelerating’ the idea in their country by making a commitment to adopt or support the initiative.

Thank you and close:
- The AMR accelerator idea with the most traction is presented during the global session.

In 2020, Reckitt and the Global Respiratory Infection Partnership (GRIP) partnered with FIP to host a series of events combining efforts with the ambition of “Driving AMR action in a new decade”. One global event and six regional workshops were held, with over 4,000 participants engaging in collaborative efforts to identify and implement region-specific initiatives to mitigate AMR. The success of this partnership culminated in the FIP Regional AMR Roadmaps which identified regional initiatives to drive behaviour change and aid in the global fight against AMR.

This year GRIP, FIP and Reckitt continue to share this global commitment as we partner to bring you a series of events aimed at further driving a collaborative approach to AMR mitigation for pharmacy. Co-chaired by regional representatives from FIP and GRIP, we will aim to showcase the progress in the AMR Roadmap made in the European Region over the past 12 months.

Moderators:
- Phillip Howard,
- Elsa Lopez Pintor
- Cátia Caneiras

Welcome and Objectives:
- Introducing regional leads and recap of ambitions of the Pharmacy AMR Roadmap

Panel Discussion:
- ‘AMR Stewardship in Action’
Regional leads to moderate a panel discussion on a total of 3 good and bad practice case studies from submissions and/or initiatives they have identified. Where possible, those involved in good practice initiatives will be invited to join the panel discussion.

AMR ACCELERATOR:
- Audience can interact with good practice initiatives, ‘accelerating’ the idea in their country by making a commitment to adopt or support the initiative.

Thank you and close:
- The AMR accelerator idea with the most traction is presented during the global session.

In 2020, Reckitt and the Global Respiratory Infection Partnership (GRIP) partnered with FIP to host a series of events combining efforts with the ambition of “Driving AMR action in a new decade”. One global event and six regional workshops were held, with over 4,000 participants engaging in collaborative efforts to identify and implement region-specific initiatives to mitigate AMR. The success of this partnership culminated in the FIP Regional AMR Roadmaps which identified regional initiatives to drive behaviour change and aid in the global fight against AMR.

This year GRIP, FIP and Reckitt continue to share this global commitment as we partner to bring you a series of events aimed at further driving a collaborative approach to AMR mitigation for pharmacy. Co-chaired by regional representatives from FIP and GRIP, we will aim to showcase the progress in the AMR Roadmap made in the Western Pacific region over the past 12 months.

Moderators:
- John Bell
- Leonila Ocampo,
- Fiona Doukas

Welcome and Objectives:
- Introducing regional leads and recap of ambitions of the Pharmacy AMR Roadmap

Panel Discussion:
- ‘AMR Stewardship in Action’
Regional leads to moderate a panel discussion on a total of 3 good and bad practice case studies from submissions and/or initiatives they have identified. Where possible, those involved in good practice initiatives will be invited to join the panel discussion.

AMR ACCELERATOR:
- Audience can interact with good practice initiatives, ‘accelerating’ the idea in their country by making a commitment to adopt or support the initiative.

Thank you and close:
- The AMR accelerator idea with the most traction is presented during the global session.

In 2020, Reckitt and the Global Respiratory Infection Partnership (GRIP) partnered with FIP to host a series of events combining efforts with the ambition of “Driving AMR action in a new decade”. One global event and six regional workshops were held, with over 4,000 participants engaging in collaborative efforts to identify and implement region-specific initiatives to mitigate AMR. The success of this partnership culminated in the FIP Regional AMR Roadmaps which identified regional initiatives to drive behaviour change and aid in the global fight against AMR.

This year GRIP, FIP and Reckitt continue to share this global commitment as we partner to bring you a series of events aimed at further driving a collaborative approach to AMR mitigation for pharmacy. Co-chaired by regional representatives from FIP and GRIP, we will aim to showcase the progress in the AMR Roadmap made in the African Region over the past 12 months.

Moderators:
- Sabiha Essack
- Mirfin Mpundu

Welcome and Objectives:
- Introducing regional leads and recap of ambitions of the Pharmacy AMR Roadmap

Panel Discussion:
- ‘AMR Stewardship in Action’
Regional leads to moderate a panel discussion on a total of 3 good and bad practice case studies from submissions and/or initiatives they have identified. Where possible, those involved in good practice initiatives will be invited to join the panel discussion.

AMR ACCELERATOR:
- Audience can interact with good practice initiatives, ‘accelerating’ the idea in their country by making a commitment to adopt or support the initiative.

Thank you and close:
- The AMR accelerator idea with the most traction is presented during the global session.

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

The 19^th episode of the Programme focuses on FIP Development Goal 17: Competency Development. The details of the Goal are available here: https://www.fip.org/fip-development-goal-17  

FIP Development Goal 17 calls for workforce and education strategies linked to the use of evidence-based developmental frameworks to support the translation of pharmaceutical practice, science and workforce & education  across all settings and according to local/national needs.

The goal calls to support professional career development by using tools, such as competency frameworks, describing competencies and behaviours across all settings.

The expected outcomes of the event are:

• Describe the FIP Development Goals and explain the components of DG 17 (and its three elements: workforce & education, science and practice).
• Showcase the FIP tools, evidence, and resources to support DG 17 implementation across the three elements.
• Identify priorities across practice, science, and workforce & education within DG 17
• Discuss the importance monitoring and evaluation through data evidence and engage participants with FIP indicators development project

Moderator:
-Wirat Tongrod,  FIP AMR committee, Vice President, The Pharmaceutical Association of Thailand under Royal Patronage, Thailand

Co-moderator:
-Ayodeji Matuluko, Remote Volunteer, FIP Commission on AMR, PhD Candidate, Glasgow Caledonian University, Nigeria

Panelists:
-Cátia Caneiras, Professor and Coordinator, Microbiology Laboratory of Environmental Health University of Lisbon, Portugal
-Chin-Yen Yeo, FIP AMR Commission - Member, Antimicrobial Stewardship Pharmacist Blacktown & Mt Druitt Hospitals, Western Sydney Local Health District, Australia
-Mirfin Mpundu, Director, ReAct Africa International Centre for Antimicrobial Resistance, Zambia
-Dalal Hammoudi, FIP WiSE steering committee and FIP AMR commission member, Associate Dean for Assessment, Lebanese International University – School of Pharmacy, Lebanon

In 2020, Reckitt and the Global Respiratory Infection Partnership (GRIP) partnered with FIP to host a series of events combining efforts with the ambition of “Driving AMR action in a new decade”. One global event and six regional workshops were held, with over 4,000 participants engaging in collaborative efforts to identify and implement region-specific initiatives to mitigate AMR. The success of this partnership culminated in the FIP Regional AMR Roadmaps which identified regional initiatives to drive behaviour change and aid in the global fight against AMR.

This year GRIP, FIP and Reckitt continue to share this global commitment as we partner to bring you a series of events aimed at further driving a collaborative approach to AMR mitigation for pharmacy. Co-chaired by regional representatives from FIP and GRIP, we will aim to showcase the progress in the AMR Roadmap made in the Americas Region over the past 12 months.

Moderators:
- Eduardo Savio
- Doug Burgoyne

Welcome and Objectives:
- Introducing regional leads and recap of ambitions of the Pharmacy AMR Roadmap

Panel Discussion:
- ‘AMR Stewardship in Action’
Regional leads to moderate a panel discussion on a total of 3 good and bad practice case studies from submissions and/or initiatives they have identified. Where possible, those involved in good practice initiatives will be invited to join the panel discussion

AMR ACCELERATOR:
- Audience can interact with good practice initiatives, ‘accelerating’ the idea in their country by making a commitment to adopt or support the initiative.

Thank you and close:
- The AMR accelerator idea with the most traction is presented during the global session.

Sore throat is a common self-limiting condition which often leads to patients presenting in the pharmacy for advice, treatment options and reassurance. Sore throat is predominantly a viral condition for which symptomatic management offers the most appropriate course of action. Effective diagnosis, communication and managing expectations can prevent unnecessary onward referral or inappropriate antibiotic use.

Aim:
To help pharmacists enhance their role as the primary healthcare professional in the appropriate management of sore throat through improved communication and appropriate management that supports self-care.

Learning objectives:
1. List the presenting symptoms of sore throat
2. Explain the diagnosis of sore throat
3. Describe an evidence-based approach to treatment options

Moderator:
-Sabiha Essack, Professor: Pharmaceutical Sciences
South African Research Chair in Antibiotic Resistance & One Health, University of KwaZulu-Natal, South Africa

Panellists:
-Douglas Bourgoyne, Principal Cooperative Benefits Group, LLC, USA
-John Bell, Community pharmacist and Self-care Advisor
Pharmaceutical Society of Australia, Australia
-Wirat Tongrod, Member of AMR Commission, Lecturer – Faculty of Pharmaceutical Sciences, Huachiew Chalermprakiat University- Thailand

Antimicrobial resistance (AMR) is a major public health threat, which currently kills around 700,000 people each year worldwide. The fight against AMR has been a priority for FIP for many years as it causes a profound impact on global, regional and national health care and economies. The goal of this webinar is to supplement the other FIP webinars being held in November 2021 discussing AMR regionally around the globe. This webinar specifically targets pharmacists involved in hospital and health-system practice settings and will discuss innovative ways to involve pharmacists in infectious disease through AMR and sepsis management.

Learning objectives:
1. Introduce the antimicrobial stewardship program in hospital pharmacy using clinical decision support system
2. Discuss the role and importance of the pharmacist in the management of sepsis
3. Evaluate the use of software and information technology to support antimicrobial stewardship in the critically ill

Moderator:
Krutika Mediwala Hornback, Clinical Pharmacy Specialist - Infectious Diseases/Antimicrobial Stewardship MUSC Health, USA

Panelists:
-Esteban Zavaleta, Director of Pharmacy, Hospital Clinica Biblica, Costa Rica
-Shu-Wen “Wendy” Lin, Director of Pharmacy, National Taiwan University Cancer Center, Taiwan
-Asad “Sid” Patanwala, Professor and Chair of Clinical Pharmacy University of Sydney | Royal Prince Alfred Hospital, Australia

The Leadership Summit– the programme finale – is a high-level event in which we recap the primary outcomes of the 12-event digital series. Together, we will adopt the FIP Commitment to Action on sustainable and equitable access to vaccines through pharmacy which will be launched during the Summit. Global leaders from health and pharmacy join this landmark event.

About the programme:

FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November.Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access and sustainability of vaccinations through policy development and implementation.

Despite all good intentions, all humans carry unconscious biases. How do these impact our ability to provide culturally appropriate care to our patients? This interactive session is meant to target all pharmacists and educators in practice to promote understanding on the influence of unconscious bias on health disparities, like COVID-19. Specifically, experts will share the neuroscience of how implicit bias, strategies to disrupt bias, and address how bias can influence our patient care interactions.

At the end of this session, participants will be able to:
1. Define implicit bias and its impact on health disparities.
2. Discuss the impact of unconscious bias and how it affects our relationships with patients, students, and colleagues.
3. Identify and reflect on own biases.
4. List strategies to mitigate unconscious bias in pharmacy practice to improve patient-centred care.

Moderator:
- Mohamed Amin, Associate Professor, Beirut Arab University, Lebanon

Facilitator:
- Dalia Bajis, FIP lead for Provision and Partnerships, FIP, Bahrain

Panellist: 
- Sally Arif, Associate Professor of Pharmacy Practice/ Clinical Pharmacist, Midwestern University College of Pharmacy/ Rush University Medical Center, USA

El documento técnico, Servicios farmacéuticos en inmunización: Aportes, experiencias e implementación en la región de las Américas, elaborado por el Centro de Información de Medicamentos del Instituto de Investigaciones Farmacéuticas de la Facultad de Farmacia de la Universidad de Costa Rica para el Foro Farmacéutico de las Américas (FFA), ofrece una visión general de la participación del profesional en farmacia en temas de vacunas y en servicios farmacéuticos en inmunización en América Latina. En este webinar de presentación, se hará una reseña de sus contenidos y la relación con los objetivos de desarrollo de la Federación Internacional Farmacéutica (FIP). Este documento tiene la pretensión de constituirse en una herramienta para la implementación de servicios farmacéuticos en inmunización en la región que complementa las formuladas y emitidas por la FIP. 

1) Reconocer la contribución del farmacéutico a las estrategias de vacunación y su relación con los objetivos de desarrollo de la FIP y las prioridades de salud globales.

2) Describir los beneficios, el impacto y las barreras de la inmunización en general y la vacunación en particular, así como experiencias de éxito del farmacéutico como inmunizador a nivel global.

3) Identificar experiencias de éxito del farmacéutico en América Latina en vacunas y su participación en las distintas etapas de la cadena de inmunización-

4) Reconocer las áreas de servicio de la inmunización en el quehacer farmacéutico y las herramientas disponibles para el desarrollo de servicios farmacéuticos de inmunización desde los diferentes ejes de su competencia.

The document "Pharmaceutical services in immunisation: Contributions, experiences and implementation in the Americas region", authored by the Drug Information Centre of the Pharmaceutical Research Institute of the Faculty of Pharmacy of the University of Costa Rica for the Pharmaceutical Forum of the Americas, provides an overview of the involvement of the pharmacy profession in immunisation in Latin America. This introductory webinar will provide an overview of the document’s content and how it relates to the FIP Development Goals. This document is intended to be a tool for the implementation of pharmaceutical services in immunisation in the region, which also complements other reports issued by FIP. The document is available in Spanish, English and Portuguese.

1) Recognise the pharmacist's contribution to immunisation strategies and their relationship to FIP Development Goals and global health priorities.

2) Describe the benefits, impact and barriers of immunisation in general and vaccination in particular, as well as successful experiences of pharmacists as immunisers globally.

3) Identify successful experiences of pharmacists in Latin America in vaccines and their participation in the different stages of the immunisation chain.

4) Recognise the service areas of immunisation in pharmacy and the tools available for the development of pharmaceutical immunisation services from the different areas of their competence.

Covid-19 complications include a wide spectrum of clinical manifestations. COVID-19 -associated invasive mould infections have been identified as a serious global health problem. These invasive infections present differently and vary in their risk factors. Pharmacists can play a vital role in raising awareness, prevention, and treatment of these emerging pathogens. In addition, pharmacists’ role is vital to providing care to patients suffering from Long Covid. Long Covid conditions are a wide range of new, returning, or ongoing health problems people can experience for four or more weeks after contracting SARS-CoV-2. These complications can occur in individuals with serious, mild, or no symptoms during the SARS-CoV-2 infection. However, the burden is not well understood and treatment approaches need further study.

This webinar will raise awareness of the pharmacist's role in supporting patients with COVID-19 associated mould infections and Long Covid.

Learning objectives:
1. Recognize manifestations and risk factors of Long Covid.
2. Provide actionable steps to care for people with post-covid conditions -as part of multi-disciplinary teams.
3. Describe common manifestations and risk factors of COVID-19-associated mould infections.
4. Identify prevention measures for COVID-19 associated mold infections.
5. Recognize treatments for COVID-19-associated mould infections.

Moderator:
- John Hertig, VP Americas (PAHO), Assoc. Prof. and Vice-Chair of Pharmacy Practice, Butler University, USA

Panelists:
-Dallas James Smith, Epidemic Intelligence Service Officer/Pharmacist Mycotic Diseases Branch, Centers for Disease Control & Prevention, United States
-Stacey L. Konkle, Epidemic Intelligence Service Officer/Epidemiologist Field Officer, Epidemiology Workforce Branch, Centers for Disease Control & Prevention, United States

This webinar aims to identify the challenges and opportunities for pharmacists in addressing diabetes, highlight the different ways pharmacists can advocate for increased recognition and visibility of roles in providing diabetes-related services, understand the role that pharmacists can play in achieving global diabetes goals, in commemoration of the 2021 World Diabetes Day (WDD). The event will culminate with the launch of the ONE FIP Practice Transformation Programme on Diabetes.

This event will also close the series of five webinars organised by FIP to explore the role of pharmacists in the prevention and management of diabetes and its complications; the advancement in therapeutic options; the competencies and workforce development opportunities; and the policy barriers and facilitators in providing diabetes-related services.

At the end of this webinar, participants will:
• Identify the challenges and opportunities for pharmacists in addressing diabetes
• Recognize the different ways pharmacists can advocate for increased recognition and visibility of roles in providing diabetes services
• Understand how the role of pharmacists can be elevated in achieving global diabetes goals, in commemoration of the 2021 World Diabetes Day (WDD) 14 November

Moderator:
-Paul Sinclair, FIP Chair Board of Pharmaceutical Practice, Community Pharmacist, Australia

Panelists:
-Tolulope Osigbesan, Advocacy and Partnerships Officer, NCDs Alliance, Switzerland
-Iryna Vlasenko, Vice president International Diabetes Federation, Ukraine
-Jean-Baptiste Nikiema, Regional advisor, EDM, WHO Regional Office for Africa, Republic of Congo
-Gonçalo  Sousa Pinto, FIP Lead for Practice Development and Transformation, Spain
-Lauren Blum, Global engagement fellow, UNC Eshelman School of Pharmacy, USA
-Rúben Viegas,FIP Practice Development Projects Coordinator, Spain
-Aniekan Ekpenyong, Practice Transformation Projects Coordinator FIP, Nigeria
-Michael Donohoe, Global Patient Advocate, A1C Wellness {Diabetes...], USA

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

The 18th episode of the Programme focuses on FIP Development Goal 3: Quality Assurance.

Learning objectives:
1. Describe the FIP Development Goals and explain the components of DG 3 (and its three elements: workforce & education, science and practice).
2. Showcase the FIP tools, evidence, and resources to support DG 3 implementation across the three elements.
3. Identify priorities across practice, science, and workforce & education within DG 3
4. Discuss the importance monitoring and evaluation through data evidence and engage participants with FIP indicators development project
Moderator:
-Banan Mukhalalati, Global Lead for Development Goal 3 “Quality Assurance” Assistant Professor, Qatar University, Qatar
Panelists:
-Mike Rouse, Former FIP Education Development Team Lead for Quality Assurance, Director, International Services, Accreditation Council for Pharmacy Education, USA
-Abby A. Kahaleh, DG3 Lead, PhD, MS, BPharm, MPH, FAACP Tenured & Board of Trustees Faculty Roosevelt University College of Science, Pharmacy, & Health, USA
-Bronwyn Clark, DG3 Lead Chief, Exec. Officer
Australian Pharmacy Council, Australia
-Abeer Alghananeem, DG3 global lead, Prof & Director of Research Sullivan University College of Pharmacy & Health Sciences, USA & Jordan
-Aline Hajj, Assoc. Prof, PharmD, PhD Researcher and Lecturer, Saint Joseph University, Lebanon
-Marwan Akel, Projects Manager Workforce FIP, Lebanon

Cytotoxic drugs compounding is one of the most risky activity among all pharmaceutical operations in a Pharmacy. This has led pharmacists to multiply check points at each critical step and in-process controls to keep that risk at the lowest, as reported in numerous publications. What can technology bring in terms of safety, speed, convenience, and reliability in such complex environments ? Three exemples will be discussed in this webinar: CSTDs, IV workflow management system with IA technology and video recording, and robotic compounding.
And if you are addicted to serious games, come and see how you can increase your competencies while training in immersive virtual reality in a real cytotoxic drugs compounding environment

Moderators:
-Jacqueline Surugue, Chair of the FIP Pharmaceutical Technology Forum, Immediate past FIP Vice President and Liaison Officer for the African Region
Hospital Pharmacist, Hospital Practitioner, Centre Hospitalier Georges Renon, Niort, France
-Josep M. Guiu Segura, HPS ExCo, Head of pharmaceutical planning and pharmacotherapy coordination Consortium of Health and Social Care of Catalonia, Spain

Panelists:
-Benoit Le Franc, Pharmacist Pharmacien hospitalier gérant PUI GHLRRA-co-fondateur chez EUREKAM SAS-inventeur Drugcam, France
-Agnés Bobay-Madic, Pharmacist Centre Hospitalier Robert Bisson, Lisieux, France
-Mirjam Crul, Pharmacist, Board Member, European Cancer Organisation, Special Network on the impact of COVID-19 on Cancer Co-Chair and workforce Network Co-Chair, The Netherlands
-Shao-Chin Chiang, Pharmacist Sun Yat-Sen Cancer Centre, Taiwan

This webinar aims to highlight strategies for developing a diabetes competent workforce, explore success stories of countries that have developed competency framework for diabetes-related roles and to identify relevant competencies essential for the delivery of diabetes services by pharmacists.

Around 422 million people worldwide have diabetes and 1. 6 million deaths are directly attributed to diabetes each year. Pharmacists, across all sectors and areas of practice do have a role to play in ensuring the prevention and management of diabetes. In a series of five webinars, the role of pharmacists in the prevention and management of diabetes and its complications; advancement in therapeutic options; competencies and workforce development opportunities; and policy barriers and facilitators in providing diabetes services will be explored. The series culminates in the launching of the ONE FIP Practice Transformation Programme on Diabetes.

At the end of this webinar, participants will:
-Understand the strategies for developing a diabetes competent workforce
-Learn from successful experiences on how to develop competency framework for diabetes related roles
-Identify relevant competencies facilitating the delivery of diabetes-related services

Moderator:
-Ralph Altiere, Chair of FIP Education (FIPEd) University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, USA

Panelists:
- Sallianne Kavanagh, Senior Lecturer- Clinical Pharmacy and Pharmacy Practice. Advanced Clinical Pharmacist. University of Huddersfield. Sheffield Teaching Hospitals NHSFT, United Kingdom
- Andreia Bruno-Tomé,  Global Lead for DG 5 - Competency Development, Senior Expert Strategist, McCann Health, Portugal
- Diana Isaacs, Endocrine Clinical Pharmacy Specialist, Cleveland Clinic, USA

In the final sixth of six regions we dissect, event 11 focuses on the regional needs and drivers for transforming vaccination in the African region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the African region join us for a true regional perspective.

About the programme – FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November.

Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access and sustainability of vaccinations through policy development and implementation.

The event will be moderated by:
- Dr. Prosper Hiag – President of the African Pharmaceutical Forum (APF)
- Mrs. Jacqueline Surugue – Chair of the FIP Technology Forum and Hospital Practicioner and Pharmacist, France
-
The speakers at the event are:
- Dr. Daniella Munene – CEO of the Pharmaceutical Society of Kenya
- Dr. Samuel Adekola – Community Pharmacist at His Grace KSP Pharmacy Group and Immediate Past National Chairman of Association of Community Pharmacists of Nigeria
- Dr. Redouane Soualmi - Vice president of international relations of Algerian Pharmaceutical Federation FAP
- Dr. Mariet Eksteen - Professional Development and Support at the Pharmaceutical Society of South Africa

This webinar aims to describe the advancement in diabetes therapeutics for managing diabetes, highlight the role of technology in improving health outcome of individuals living with diabetes and identify the different services employed in the optimization of diabetes treatment.

Around 422 million people worldwide have diabetes and 1. 6 million deaths are directly attributed to diabetes each year. Pharmacists, across all sectors and areas of practice do have a role to play in ensuring the prevention and management of diabetes. In a series of five webinars, the role of pharmacists in the prevention and management of diabetes and its complications; advancement in therapeutic options; competencies and workforce development opportunities; and policy barriers and facilitators in providing diabetes services will be explored. The series culminates in the launching of the ONE FIP Practice Transformation Programme on Diabetes

At the end of this webinar, participants will:

• Describe the advancement in diabetes therapeutics for managing diabetes
• Explain the role of technology in improving health outcome of individuals living with diabetes
• Identify the different services employed in the optimization of diabetes treatment

Moderator:
Ross McKinnon, Chair of BPS, Chair of Board of Pharmaceutical Sciences, FIP Australia

Panelists:
-Antria Pavlidou, YPG PharmSci Promotion, PhD Candidate, Clinical Pharmacist  Pharmaceutical Services, Ministry of Health, Cyprus / PhD Candidate UCL, Cyprus
-Kalyan Venkata, Assistant Professor, Medicinal Chemistry, Pharmaceutical and Administrative Sciences,
University of Health Sciences and Pharmacy in St. Louis, USA
-Anna Busquets Casso, Community pharmacist, SEFAC, Spain

In the fifth of six regions we dissect, event 10 focuses on the regional needs and drivers for transforming vaccination in the Western Pacific region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the Western Pacific region join us for a true regional perspective.

About the programme – FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November.

Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access and sustainability of vaccinations through policy development and implementation.

The event will be moderated by:
• Mr. John Jackson - President of the Western Pacific Pharmaceutical Forum, Australia
• Professor Parisa Aslani - Professor in Medicines Use Optimisation at The University of Sydney and FIP Vice President

Panelists:
- Dr. Amrahi Buang - President of the Malaysian Pharmacists Society (MPS)
- Dr. Stephanie Tay - Senior Manager at the Ministry of Health, Singapore
- Mrs. Leonila M. Ocampo - Former President and Member of the Council of Advisers, Philippine Pharmacists’ Association
- Mr. Chris Campbell - General Manager, Policy & Program Delivery and Queensland State Manager at the Pharmaceutical Society of Australia

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

The expected outcomes of the event are:
1. Describe the FIP Development Goals and explain the components of DG 5 (and its three elements: workforce & education, science and practice).
2. Showcase the FIP tools, evidence, and resources to support DG 5 implementation across the three elements.
3. Identify priorities across practice, science, and workforce & education within DG 5
4. Discuss the importance monitoring and evaluation through data evidence and engage participants with FIP indicators development project

Moderators:
-Elizabeth McCourt, Health Professional Research Coordinator Queensland Health, Australia
-Marwan Akel, FIP projects manager- workforce, FIP Lebanon

Panelists:
-Arijana Meštrović, FIP ACPS Vice President, FIP WDH Global Lead for Competency Development Director, Professional services Pharma Expert, Croatia
-Sylvain Grenier, MEPS president Director Plasma Protein and related products Canadian Blood Services,
Canada
-Andreia Bruno-Tome, Global Lead for DG 5 - Competency Development ,Senior Expert Strategist
McCann Health, Portugal
-Naoko Arakawa, Global Lead for Competency Development, Assistant Professor in International Pharmacy, University of Nottingham, UK

In the fourth of six regions we dissect, event 9 focuses on the regional needs and drivers for transforming vaccination in the South East Asian region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the South East Asian region join us for a true regional perspective.

About the programme – FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November.

Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access and sustainability of vaccinations through policy development and implementation.

The event will be moderated by:
• Chinta Abaywardana – Editor, Pharmaceutical Society of Sri Lanka
• Sherly Meilianti – Data and Intelligence Specialist, FIP

The speakers at the event are:
• Rao Vadlamudi – Professional Secretary of SEARPhorum
• Bhojraj Suresh - Pro Chancellor, JSS Academy of Higher Education and Research, India
• Keri Lestari - Lecturer and Pharmacist, Universitas Padjadjaran, Indonesia
• Vindya Pathiraja - General Secretary of the Pharmaceutical Society of Sri Lanka
• Sanjeev Sharma Kattel - Pharmacy Officer/Acting Chief, Department Of Drug Administration, Kathmandu, Nepal

3D printing offers the potential to revolutionise the production of pharmaceuticals targeted to the gastrointestinal tract by offering a flexible drug product manufacturing platform that can adapt readily to changing market and patient needs.
When will a pharmacist be able to use each patient’s individual information — such as age, race, gender or constitution — to produce their optimal medication dose, rather than relying on a standard set of doses? Could there be a time when a pharmacist will be able to print drugs in a complex construct of layers? When will patients be able to print their medicines at home?

Describe the generalities related to 3D printing of medicines.
Understand the opportunities, issues and regulation related to 3D printing of medicines.
Learn how different technological tools allow personalised 3D printed medicines.
Outline a practical experience in 3D printing in pharmacies

Moderator:
- Jaime Acosta, Community Pharmacy Section’s Executive Committee Member, FIP CPS, Spain

Panellists:
- Alvaro Goyanes Goyanes, Co-founder and Director of Development, FabRx Ltd, United Kingdom
- Patrick van Oirschot, Director | Consultant, GPP Support, Netherlands
- Jan Saevels, Scientific Director, Association of Pharmacists Belgium (APB), Belgium

On 25 October 2021, it will be the third anniversary of the World Health Organization’s Astana Declaration on Primary Health Care (PHC), for which FIP pledged its commitment to accelerate progress in strengthening PHC. In 2020, the WHO published its Operational Framework for PHC to translate the vision of the Astana Declaration into actions. To mark this date and showcase how pharmacists can utilise and contribute to the WHO operational framework, FIP is organizing the digital FIP Global Summit on Primary Health Care. The summit will host a high-level discussion with the WHO to explore the strategic levers needed for pharmacists to strengthen primary health care.

At the end of this session, participants will:

1. Learn about WHO’s operational framework on primary health care to translate vision into actions
2. Explore initiatives from FIP member organizations on primary health care
3. Engage in a high-level discussion on strategic priorities needed for pharmacists to strengthen primary health care

Co-Moderator:
- Dominique Jordan, President FIP - Switzerland

Co-Moderator:
- Paul Sinclair, Chair of the Board of Pharmaceutical Practice, FIP - Australia

Facilitator:
- Nilhan Uzman, FIP Lead for Education Policy and Implementation, FIP - The Netherlands
- Aysu Selcuk, FIP Educational Partnership Coordinator, FIP - Turkey

Panellists:
- Catherine Duggan, CEO, FIP - The Netherlands
- Nisa Masyitah, Master's Student, The Graduate Institute of International and Development Studies (IHEID) - Switzerland
- Shannon Barkley, Technical Officer, Primary health care World Health Organization/HQ - Switzerland
- Anne L. Burns, Vice President of Professional Affairs, American Pharmacists Association - United States
- Eric Muringu, Projects Lead, Pharmaceutical Society of Kenya - Kenya
- Yong Pei Chean, President, Pharmaceutical Society of Singapore - Singapore
- Anoushka Schut, Heading the Policy & Development Cluster, Member of the Management Team of pharmacist association - The Netherlands
- Roy Himawan, Head of Program and Information Section Secretariat of the Directorate General of Pharmacy and Medical Devices at Ministry of Health, Indonesian Pharmacists Association / Ministry of Health, Indonesia
- Zeid Kilani, President, JAP, Jordan

This webinar aims to describe the different services provided by pharmacists to manage diabetes, explore the role of pharmacists in preventing the complications of diabetes, and highlight the importance of collaboration with other health professionals in achieving treatment goals

Around 422 million people worldwide have diabetes and 1. 6 million deaths are directly attributed to diabetes each year. Pharmacists, across all sectors and areas of practice do have a role to play in ensuring the prevention and management of diabetes. In a series of five webinars, the role of pharmacists in the prevention and management of diabetes and its complications; advancement in therapeutic options; competencies and workforce development opportunities; and policy barriers and facilitators in providing diabetes services will be explored. The series culminates in the launching of the ONE FIP Practice Transformation Programme on Diabetes.

At the end of this webinar, participants will:

• Describe the different services provided by pharmacists to manage diabetes
• Identify the role of pharmacists in preventing the complications of diabetes
• Understand the importance of collaboration with other diabetes health professionals in achieving treatment goals

Modarator:
Tim Chen, President FIP Social and Administrative Pharmacy Section,
Australia

Panelists:
-Sanah Hasan, President of FIP Social and Administrative Pharmacy Section, Associate Professor Ajman University, College of Pharmacy and Health Sciences, United Arab Emirates
-Astrid Czock, FIP Global Lead for DG8: Working with others, CEO QualiCCare, Switzerland
-Francisco Javier Jiménez Ramírez, Professor / Pharmacist University of Puerto Rico School of Pharmacy,
Puerto Rico
- Mara Pereira Guerreiro, Invited Professor, Nursing School of Lisbon & Instituto Universitário Egas Moniz Nursing School of Lisbon & Instituto Universitário Egas Moniz, Portugal

Vaccination coverage rates for several diseases are suboptimal and remain below WHO targets in many countries of all income levels. For FIP, it is essential to engage with civil society organisations representing different constituencies – from patient advocacy groups to older adult organisations and to vaccination advocates – to discuss and outline synergistic and complementary advocacy actions for broader access and convenience of vaccination services through a diversity of providers and pathways. This event will gather different civil society organisations to express their concerns, best practices and expectations, namely with regards to the role of pharmacists, for improving vaccination coverage, and to identify potential alignments in advocacy strategies.

Learning objectives:
1. Understand the role of the various civil society organisations in contributing to increased vaccination coverage.
2. Explore drivers and barriers to diversifying vaccination pathways and providers, allowing for better access to vaccination services.
3. Discuss possible actions and synergies by the different stakeholders in addressing vaccine hesitancy and complacency.

Moderator:
- Catherine Duggan, CEO, FIP

Panellists:
- Jane Barratt , Secretary General, International Federation on Ageing
- Mariano Votta, Director, Active Citizenship Network
- Iryna Vlasenko, Vice president, International Diabetes Federation
- Siân Williams, CEO, International Primary Care Respiratory Group
- Gary Finnegan, Editor, Vaccines Today

Ten years after the first FIP Pharmacy Technicians’ Symposium, we invite you to attend this year’s virtual event. The 2021 Pharmacy Technicians’ Symposium will take place on 19 and 20 October in celebration of World Pharmacy Technician Day (October 19). Take a look at the full programme here: https://bit.ly/3a8fGfa

Symposium Programme

13:00 - 14:30 CEST

Trends in digital health technologies require the entire pharmacy workforce to prepare for and adapt to constant change.
This session will explore how pharmacy technicians can best engage in advances in digital health.

Learning Objectives:
● Recognize emerging trends in digital health technologies
● Identify digital tools that aid in the delivery of patient care
● Describe the role of pharmacy technicians in digital health

Chairs: Christina Durinck (Denmark) & Ryan Burke (US)

Speakers:
● Jacqueline Surugue (France)
● Vijay Sarma (Canada)
● Peter Karegwa Mwangi (Kenya)
● Giada Crivelli & Karen Chin (Australia)

14:30 - 14:35 CEST Break

14:35 - 15:50 CEST
Unique Pharmacy Technician Activities “Things you didn't know pharmacy technicians do”

Pharmacy technicians across the globe play a key role in all aspects of pharmacy practice. Some roles are well known, while others are less common but equally important in terms of patient care.

This presentation will focus on unique roles for pharmacy technicians, including academia, radiopharmaceuticals, transplant, medicines administration, and more.

Learning Objectives:
● Identify unique roles for pharmacy technicians
● Describe the education, training, and experience required for pharmacy technicians to engage in certain areas of pharmacy practice
● Recognize the key tasks and responsibilities of pharmacy technicians working in transplant, medication administration, smoking cessation, and pharmaceutical manufacturing and distribution.

Chairs: Tamara Koehler (Netherlands) & Cathy Schuster (Canada)

Speakers:
● Amareen Kamboh & Claire Williams (UK)
● Rachelle Shelkey (Canada)
● Karen Hemmingsen (Denmark)
● Marianne Timm (Denmark)

15:50 - 16:00 CEST Symposium Closing Remarks

“This webinar is part of the FIP virtual Global Pharmacy Technicians’ Symposium 2021 programme! The symposium will continue on 19 October at 15:00 CEST and on 20 October at 13:00 CEST. Take a look at the full programme and register for each day here: https://bit.ly/3a8fGfa”

Moderator:
-Marwan Akel, FIP projects manager- workforce FIP, Lebanon

Panelists:
-Silvana Nair Leite, DG 8 Leads, Hub, Professor Universidade Federal de Santa Catarina, Brazil
-Victoria Garcia Cardenas, Chair, Pharmacy Practice Research SIG, Senior Lecturer, Pharmacy University of Technology Sydney, Australia
-Mujahidhussein G Valji, Vice President, Hospital Pharmacy Section, Africa Region Chief Pharmacist Aga Khan Health Services, Tanzania
-Susan James, Lead for the FIPEd Pharmacy Technicians and Support Workforce Strategic Platform and Chair, Pharmacy Technician Advisory Committee Director, Quality Ontario College of Pharmacists, Canada
-Daragh Connolly, Interim President, Community Pharmacy Section, FIP ExOfficio President Irish Pharmacy Union, Ireland
-Astrid Czock, FIP Global Lead for DG8: Working with others, CEO QualiCCare, Switzerland
-Jill Martin Boone, Associate Director, HUB
DG8 lead, Director of Interprofessional Education James L. Winkle College of Pharmacy
University of Cincinnati, USA

Ten years after the first FIP Pharmacy Technicians’ Symposium, we invite you to attend this year’s virtual event. The 2021 Pharmacy Technicians’ Symposium will take place on 19 and 20 October in celebration of World Pharmacy Technician Day (October 19). Take a look at the full programme here: https://bit.ly/3a8fGfa

15:00 – 15:30 CEST Opening session - FIP HQ Representatives / Leadership

15:30 - 17:00 CEST Leadership and Pharmacy Technician Workforce Development

Description: A strong pharmacy support workforce is a key component of FIP’s workforce development initiatives. This session will explore leadership roles and opportunities for pharmacy technicians and highlight strategies for further developing the pharmacy technician workforce.

Learning Objectives:
● Identify FIP Workforce Development Goals related to the pharmacy support workforce.
● Review leadership roles and opportunities for pharmacy technicians
● Describe pharmacy technician career ladders
● Discuss professional development strategies for pharmacy technicians

Chairs: Liz Fidler (UK) & Zachary Green (US)

Speakers:
● Kate Thorndike (UK)
● Vibhuti Arya (US)
● Jill Boone (US)
● Abigail Tan Ming Li (Singapore)

Pharmacy and pharmaceutical sciences encompass a very diverse field. The options are almost infinite as science and practice evolves. It is therefore of great advantage for young pharmacists if they can discover their path early on in their careers.
In this webinar, information about different career paths and opportunities will be shared with participants with the aim of helping them navigate the career paths and opportunities in diverse settings and specialist areas.

By the end of the webinar, participants will be able.
1. To understand the possible career paths and opportunities for young pharmacists in industrial pharmacy.
2. To understand the possible career paths and opportunities for young pharmacists in Academia.
3. To understand the possible career paths and opportunities for young pharmacist in regulatory pharmacy.

Moderator:
-Onyeka Obidiegwu, Member relations Coordinator, FIP YPG Subcommittee 2021, Pharmacist Nnamdi Azikiwe University, Awka Nigeria

Panelists:
-Clement Haeck, FIP YPG Twitter Manager, FIP YPG Subcommittee 2021 Researcher The Population Council, USA
-Yoonjung Choi, Member/Previous Career Development Toolkit Working Group, Research Scientist
Korea Institute for Pharmaceutical Policy Affairs Republic of Korea
-Anisha Sandhu, FIP YPG Workforce Development Hub Liaison, Assistant Lecturer Monash University Malaysia, Malaysia
-Angeliki Kopsini, Medical Science Liaison Cardiovascular Bayer Hellas, Pharmaceutical Division, Greece

Hygiene practices including hand and surface disinfection form part of our first line of defence by helping to reduce the spread of the infections such as COVID-19. These interventions also have an impact on many common infections such as cold and seasonal flu. The pharmacy team are the most accessible healthcare provider and are a convenient source of advice for patients and public in the maintenance of appropriate hand and surface hygiene practices.

Aim:
To explain the benefits of hand and surface disinfection in stopping the transmission of a range of common infections that are transmitted in the home and everyday life setting and profile the role the pharmacy team can play in providing patient and public education on disinfection in disease containment and management.

Learning objectives:
1. Explain the importance of hand and surface disinfection
2. List common infections/conditions where hand or surface transmission plays a role
3. Discuss the evidence-base for disinfection practice including use of appropriate disinfectants
4. Describe the role that pharmacist and their team can play in advising and education patients and public about disinfection.


Moderator:
-Cátia Caneiras, Professor and Coordinator, Microbiology Laboratory of Environmental Health University of Lisbon, Portugal

Panelists:
-Sally Bloomfield, Honorary Professor London School of Hygiene and Tropical Medicine, UK
-Dalal Hammoudi, Assistant Professor Chairperson; Pharmaceutical Sciences Department School of Pharmacy; Lebanese International University, Lebanon
-Mirfin Mpundu, Director, ReAct Africa International Centre for Antimicrobial Resistance, Zambia

In the third of six regions we focuses on the regional needs and drivers for transforming vaccination in the European region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the European region join us for a true regional perspective.

About the programme – FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November.

Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access, and sustainability of vaccinations through policy development and implementation.

The event will be moderated by:
• Ema Paulino – Immediate Past Professional Secretary at the International Pharmaceutical Federation (FIP) – Portugal
• Stephanie Kohl - Policy & Advocacy Officer at the European Association of Hospital Pharmacists (EAHP) – Belgium

The speakers at the event are:
- Koen Straetmans - President of the Belgian Pharmaceutical Association (APB)
- Piotr Merks – Adjunct professor at the Faculty of Medicine, Cardinal Stefan Wyszynski University in Warsaw,
- Vibhu Paudyal - Senior Lecturer in Clinical Pharmacy, University of Birmingham and Chair of the Research Committee at the European Society of Clinical Pharmacy (ESCP)
- Monika Derecque-Pois - Director General of the European Healthcare Distribution Association (GIRP)
- Mary Ann Sant Fournier - President of Malta Chamber of Pharmacists

Anticoagulant therapy requires appropriate monitoring and management to ensure safety and effectiveness of the treatment, avoid complications and to achieve optimal clinical outcomes. Pharmacists can play an important role in anticoagulation therapy management through their expert knowledge of medicines. This role also includes the provision of patient education, identification of drug interactions, monitoring for dose appropriateness and checking for adverse effects. This webinar will explore the various roles that pharmacists can play in providing anticoagulation management services.

At the end of this webinar, participants will:
1. Identify the different issues impacting anticoagulation management
2. Recognize the crucial role of pharmacists in enhancing the management of anticoagulation
3. Explain the role technology can play in supporting anticoagulation management
4. Describe the barriers and opportunities for pharmacists in leading anticoagulation management services

Moderator:
Carlos Lacava Fernández, Vice President of FIP, Uruguay

Panelists:
-Sahimi Mohamed, Clinical Pharmacist Hospital Serdang, Ministry of Health, Malaysia
-Nida Najmi, Founder of Online Anticoagulation
Management Services & Mahir-e-Adviyat, Pakistan
-Rose Anne, Coordinator, Anticoagulation Stewardship Program, University of Wisconsin Hospital and Health System (UW Health), Madison, Wisconsin, USA

To advocate for broader, harmonized implementation of biopharmaceutics classification system (BCS)-based biowaivers in Latin American countries, FIP is supporting regional leaders in raising awareness for this science-based regulatory pathway designed to accelerate market approval of safe and effective generic drug products. The first part of this webinar series specifically designed for the Latin American region centers on the fundamental scientific concepts underlying the BCS-based biowaiver regulatory pathway. Experts will address the different tools that can be applied to generate valid scientific evidence in support of BCS-based biowaiver applications.

In collaboration with Sindusfarma, Legis Consultoria, and Innovation and Biopharmaceutical Evaluation Center. 

This webinar has the objectives:

• To differentiate between in vivo bioequivalence and BCS-based biowaiver regulatory strategies for approval of generic drug products.
• To understand the scientific principles guiding the BCS-based biowaiver regulatory pathway.
• To delineate the contributions of solubility, permeability, and dissolution for BCS-based biowaiver applications.

Moderator:
- Talita Ferreira, Latin America Biowaiver Project Manager, International Pharmaceutical Federation (FIP) - Brazil

Panellists:
- Maria del Val (Marival) Bermejo Sanz, Professor, Miguel Hernández University - Spain
- Isabel González, Professor, Miguel Hernández University - Spain
- Gladys Granero, Professor, University of Córdoba - Argentina
- Pablo González, CEO, Innovation and Biopharmaceutical Evaluation Center, Chile
- Miguel Angel Cabrera-Pérez, Associate Professor, Central University of Las Villas, Cuba

Building on World Health Professions Alliance (WHPA), Positive Practice Environments Campaign, the “FIPWiSE toolkit for positive practice environments in education & science” is developed to identify and address inequalities in the workplace environments which affects women in pharmaceutical science and pharmacy education, with transferable learnings across the pharmaceutical workforce. The toolkit is designed to raise awareness and provide possible solutions for individuals, employers and institutions that can enable positive practice environments for women in pharmaceutical science and pharmacy education.

Learning objectives:
1. Explore the key factors that enable positive practice environments for women in pharmaceutical science and pharmacy education, and the entire pharmaceutical workforce
2. Learn about practical solutions for professionals, employers and policy makers in creating positive practice environments for women in pharmaceutical science and pharmacy education
3. Discuss with the toolkit authors and high-level speakers how to take action and standi up for positive practice environments

Moderator:
- Claire Thompson, Chair of FIPWiSE - UK
Facilitator:
- Nilhan Uzman, FIP Lead for Education Policy and Implementation - Netherlands

Panellists:
- Dominique Jordan, President FIP,Switzerland
- Catherine Duggan, CEO FIP, FIPWiSE Executive Sponsor,Netherlands
- Dalal Hammoudi, FIP WiSE steering committee member & FIP AMR commission member,Lebanon
- Ecehan Balta, FIPWiSE working group member,Turkey
- Nisa Masyitah, FIPWiSE Remote volunteer,Switzerland
- Alison Etukakpan, FIPWiSE working group member, Educational partnership coordinator FIP,Nigeria
- Aysu Selcuk, FIP Educational Partnerships Coordinator, FIPWiSE project coordinator,Turkey
- Belma Pehlivanović, FIPWiSE Remote volunteer,Bosnia and Herzegovina
- Esther Anyango, FIPWiSE Remote volunteer,Kenya
- Iris Mwanza, WGH Co-chair,USA
- Lina Bader, FIP Lead for EquityRx Program,SA

This digital event will discuss how important it is to promote confidence in influenza vaccines and avoid complacency towards vaccination due to lower influenza rates in the past year. Harnessing the convenience of access to pharmacies will be paramount to achieve these goals. Due to the widespread adoption of disease prevention measures to reduce transmission of COVID-19, the prevalence of the seasonal influenza lowered drastically around the world. However, as more people become vaccinated against COVID-19 and measures such as mask wearing, social distancing and home-based working or schooling are eased, the flu could return with high incidence rates and people could be more susceptible to the influenza virus due to lack of recent exposure. Developing flu vaccines this year has also been more challenging than usual due to less data available. This uncertainty around the return of influenza makes vaccination all the more critical, and it essential to communicate this to the population.

Learning objectives:
1. Discuss the impact of COVID-19 pandemic on the prevalence and evolution of the seasonal influenza around the world.
2. Explore relevance and importance of the influenza vaccination in the coming seasons.
3. Discuss ways to effectively develop confidence in influenza vaccines among the public.
4. Share learnings to address complacency towards the influenza vaccination including harnessing the role of community pharmacists.

Moderator:
-Luís Lourenço, Professional Secretary FIP, Portugal

Panellists:
-Lyn Morgan, Coordinator, Policy & Communications group, Influenza Vaccines Suppliers International Federation of Pharmaceutical Manufacturers’ Associations, France
-Samantha Marsh, Research fellow University of Auckland, National Institute for Health Innovation, New Zealand
- Dermot Twomey, President Irish Pharmacy Union, Ireland
- Danielle Paes, Chief Pharmacist Officer Canadian Pharmacists’ Association, Canada

New niche & digital actors as well as on-line pharmacies are entering the pharmacy market. Healthcare is becoming more and more digital, and the development is partly exponential, and partly driven by the consumers – as such there is a consumerism of healthcare. How will this affect the patients, the current pharmacy model & the healthcare systems?

Learning objectives:

• Understand the changing landscape of healthcare and pharmacy
• Identify how new actors use technology to transform pharmacy services
• Understand how digital transformation and tools support new business models and services, as well as is shaping a new patient/consumer behaviour
• Describe how FIPs PHC strategy and the DGs can be used to transform pharmacy practice
• Define a strategy for transform pharmacy linked to the "new normal"

Moderator:

• Lars-Åke Söderlund, President the FIP Community Pharmacy Section, Executive Advisor at Apoteket AB, Sweden
• Jacqueline Surugue, FIP Vice President, FIP Technology Forum Chair, Hospital Pharmacist at a 1300 beds hospital, France 

This webinar aims to highlight the different services provided by pharmacists in the prevention, screening and detection of diabetes. It will also demonstrate how pharmacists are providing such services in a time of pandemic.

Around 422 million people worldwide have diabetes and 1. 6 million deaths are directly attributed to diabetes each year. Pharmacists, across all sectors and areas of practice do have a role to play in ensuring the prevention and management of diabetes. In a series of five webinars, the role of pharmacists in the prevention and management of diabetes and its complications; advancement in therapeutic options; competencies and workforce development opportunities; and policy barriers and facilitators in providing diabetes services will be explored. The series culminates in the launching of the ONE FIP Practice Transformation Programme on Diabetes.

At the end of this webinar, participants will:
1. Become familiar with services that pharmacists can provide in promoting the awareness of diabetes and adoption of healthy lifestyle
2. Recognise the role of pharmacists in the screening and detection of diabetes
3. Describe how the pandemic has influenced the delivery of diabetes services by pharmacists.

Moderator:
- Manjiri Gharat, FIP Vice-President, FIP, India

Panellists:
- Paula Teixeira, Scientific Information Manager, Center for Medicines Information and Health Interventions (CEDIME) in the Portuguese National Association of Pharmacies (ANF), Portugal
- Margaret Wonah, Pharmacist, The Diabetes Care Network, Nigeria
- Mohamed Hassan Elnaem, Assistant Professor of Clinical Pharmacy, Department of Pharmacy Practice, Faculty of Pharmacy, International Islamic University, Malaysia

In the second of six regions we dissect, event 7 focuses on the regional needs and drivers for transforming vaccination in the Eastern Mediterranean region. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the Eastern Mediterranean region join us for a true regional perspective.

About the programme – FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November.

Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access and sustainability of vaccinations through policy development and implementation.

The event will be moderated by:
- Dr. Ayman Noreddin - EMRO Education Leader and Dean at the College of Pharmacy, Galala University
- Dr. Lina Bader - Lead for Workforce Transformation & Development at FIP

The speakers at the event are:
- Dr. Ziad Nassour - Former President of the Lebanese Order of Pharmacists
- Dr. Madeeha Malik - Director/Professor - Hamdard Institute of Pharmaceutical Sciences
- Dr. Mohammed Al-Nuzili - Governing Board President of Yemen Community Pharmacy Syndicate
- Mr. Ahmed Abdulbary - Senior Regulatory Affairs Pharmacist at the National Health Regulatory Authority
- Prof. Rula Darwish – Professor at the University of Jordan. WDG9 Lead and member of executive committee of FIP academic section, and CPD chair of Jordan Pharmacist Association

This event will ask how healthcare can be rebuilt amidst a global pandemic and focus on the important role that selfcare will play. It will also look at the enablers that will accelerate self-care through community pharmacy and how this builds towards Universal Health Coverage.

Aim:
To identify mechanisms that will enable the acceleration of self-care to achieve UHC.

Learning objectives:
1. Discuss approaches to rebuilding healthcare during the COVID-19 pandemic
2. List factors that enable self-care through community pharmacy;
3. Describe trends in self-care;
4. Explain how to integrate self-care as a building block to Universal Health Coverage.

Target audience: Healthcare professionals – particularly the pharmacy team, who support people to self-care.

Moderator:
Sham Moodley, Community pharmacist

Panellists:
- Jurate Svarcaite, Director General Association of the European Self-Care Industry
- Ruben Viegas, FIP Practice Development Projects Coordinator
- Padmaja Kamath, Director – Regulatory and Scientific Affairs, Global Self-care Federation

The COVID-19 pandemic has exacerbated the existing mental health crisis. People have reportedly been affected by worry, anxiety and fear due to the pandemic. This has placed a huge strain on health systems and their ability to deliver mental health care. Pharmacists are the most accessible healthcare providers and consistently rank among the most trusted health professionals. Hence, they can play an important role in the provision of mental health services to the public, thereby helping improve health outcomes and ameliorate the impact on health systems. This webinar explores the different services offered by pharmacists to improve mental health in an era of COVID-19 and beyond.

At the end of this webinar, participants will:
1. Recognize the role of pharmacists in addressing the mental health crisis.
2. Understand the needs of people living with mental health illness
3. Describe the various services offered by pharmacists to members of the public in the area of mental health.
4. Be familiar with the tools and resources available for pharmacists to improve the mental health of their patients.

Moderator:
-Sarira El-Den, Lecturer School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Australia

Panellists:
- Claire O’Reilly, Senior Lecturer School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Australia
- David Odhiambo, Pharmacist, Kenya
- Andrea Murphy, Associate Professor, Dalhousie University, Canada
- David Gardner, Professor, Dalhousie University, Canada
- Helena Roennfeldt, Consumer Mentor, Griffith University, Australia

This webinar will present the professional practice in the hospital setting using health digital technologies. Digital Innovation, how to develop digital skills in pharmacy personnel Telepharmacy and mHealth is the content of the first part. It is relevant to discuss “mHealth” because the access to mobile phones is almost universal and the costs of this technology will be able to be addressed by many countries. The objective of the second part will be: “Discuss current use of mHealth by patients and providers and the impact on hospital care in Midwestern United States” "Medication use technology" would complete the webinar.

Learning objectives:
1. Compare the “European” model of digital technologies for hospital pharmacy with the “American” one.
2. Explain the concept of medication error risk mitigation.
3. Get aware with Medication Use Technology employed throughout the medication use process

Moderator:
- Jacqueline Surugue, Chair of the FIP Pharmaceutical Technology Forum, France 

Panellists:
- José Manuel Martínez Sesmero, Director of Pharmacy in Hospital Clínico San Carlos (Madrid), Spain
- Katherine A. Miller, Sr. Director – Acute Care Pharmacy and Clinical Nutrition,The University of Kansas Health System, USA
- Dr. Johlee S. Odinet, Johlee S. Odinet Medication Safety Supervisor  Ochsner Medical Center, USA

En la primera de las seis regiones que analizaremos, este evento se centrará en las necesidades y los catalizadores a nivel regional para transformar las estrategias de vacunación en las Américas. Se trata de identificar las prioridades de los países de la región en materia de equidad y acceso a la vacunación. También discutiremos las barreras, los desafíos y las necesidades regionales en relación con el establecimiento de políticas de vacunación. Los miembros de la FIP, y otras organizaciones y socios relevantes de la región de las Américas participarán conjuntamente para obtener una verdadera perspectiva regional sobre este asunto.

Acerca del programa - El programa digital 2021 de la FIP para transformar la vacunación a nivel mundial, regional y nacional comprende dos series, con un total de 12 eventos que se desarrollarán entre junio y noviembre.

In the first of six regions we dissect, event 6 focuses on the regional needs and drivers for transforming vaccination in the Americas. This involves identifying priorities in the region’s countries with regards equity and access to vaccinations. We also discuss barriers and challenges and regional needs in relation to policy setting. FIP members, stakeholders and partners from the Americas region, join us for a true regional perspective.

This event will be moderated by:

• Eduardo Savio – President of the Pharmaceutical Forum of the Americas, Uruguay
• Carlos Lacava – Vice President of Uruguayan Association of Chemistry and Pharmacy

The speakers at the event are:

• Dr. Kasey Thomspon - Chief Operating Officer and Senior Vice President of the American Society of Health-System Pharmacists (ASHP), USA
• Martha Rebour - Executive Director at Shot@Life, United Nations Foundation, USA
• Dr. Magaly Rodriguez de Bittner - Vice-President Pharmaceutical Forum of the Americas, USA

Facillitator:

• Rúben Viegas, Practice Development Projects Coordinator FIP, Spain

mRNA technology was used in developing the first ever COVID vaccine, developed by Pfizer / BioNtech. A number of vaccine or therapeutic products are in developing this technology. This webinare will address the following:

• What is mRNA? (structure and chemistry)
• How does it work in a cell (as either a therapeutic or vaccine)?
• How is it made and at what scale?
• How is it analyzed and characterized?
• By what means can it be delivered to the patient?
• What were the biggest challenges to get mRNA vaccines out to the public in 2020?
• What other notable clinical advances have been made for mRNA based medicines?
• What future directions do we see for mRNA as a therapeutic tool?

Moderator:

• Mathew Cherian, ExCo Member, Industrial Pharmacy Section Consultant, USA

Panellists:

• Michael McCaman PhD (U Cal at Davis), Managing Director, BDO USA
• Seth Alexandert PhD (Yale), Associate Director, Resilience, USA

This event will focus on the role that pharmacists can play in providing pharmaceutical care for people with hearing impairment or a disability linked to hearing loss. Pharmacists must provide clear messages and adapt their communication strategies to this particular population group to ensure optimal use of medicines and medical devices, and they need to have the knowledge and skills to do so. Also, people with hearing loss face different challenges and this problem becomes more relevant with age. Pharmacists can support patients in detecting early signs of hearing loss and taking the appropriate actions.

Learning objectives:

• Understand how hearing impairment or deafness impact a patient’s quality of life and their capacity to communicate with healthcare professionals.
• Learn about what pharmacists can do to support patients and carers with these conditions.
• Improve communication strategies to advise patients with hearing impairment on how to achieve an optimal use of medicines and medical devices.

Moderator:

• Tara Hehir, SAPS Secretary, Consultant Pharmacist, Australia

Panellists:

• Kasper Bergmann, Vice President World Federation of the Deaf, Denmark
• Kenneth Bitrus David, MSc Pharmacology and Drug Development Candidate Hull York Medical School, University of Hull, Nigeria/ United Kingdom
• Fiorella Donato Zúñiga, Pharmacist, Coordinator of "Programa Salud Inclusiva" (Inclusive Health Program) Acceso Visual , Costa Rica

Poor medication adherence has emerged as a major public health concern in the last decade, and pharmacists may play a vital role in medication adherence by implementing many of the solutions demonstrated at COVID-19.

FIP adapted the theme "Pharmacy: Always trusted for your health" for World Pharmacy Week; and expanding on that theme, FIP would like to welcome your attendance to this event. The event has been sponsored by an unrestricted educational grant by Pfizer.

The expected outcomes of the event are:
1 to discuss the role of pharmacists in medication adherence and communication.
2 to share some regional and global thoughts on the common communication gaps and challenges that are experienced in all patient facing sectors
3 to highlight various regional and global strengths, accomplishments, and success stories in terms of medication adherence and communication in pharmacy.

FIP Technology Forum brings you the webinar about Virtual reality (VR). VR has been widely studied and applied in numerous medical applications. In pharmacy, VR can potentially be applied in wide range of activities, from drug design and discovery, though pharmacist education, to in-patient counseling and behavior modification. In this webinar we bring you the examples of VR technology applications in pharmacy. In our webinar, we will showcase and immersive virtual reality in a virtual environment with experience from Finland with our speaker Mia Siven from Helsinki University, where the VR was successfully applied in pharmacy education. We will then present a showcase of immersive virtual reality in a real environment, with speakers Agnes Bobay Madic and Paul Besnier with their example from France. VR technology has become increasingly affordable, flexible, and portable, enabling its use for therapeutic purposes in both inpatient and outpatient environments. But despite the compelling features of VR, a number of challenges exist, such as validation of clinical efficacy, cost/accessibility and usability issues, technical capabilities, acceptance, among others. You will have the opportunity to ask questions in the panel discussion part of the webinar.

Moderator:

• Jacqueline Surugue, FIP Vice President, Hospital Pharmacist, France

Panellists:

• Eeva Teräsalmi, Community Pharmacist, Owner Seven Brothers Pharmacy, Helsinki, Finland
• Mia Siven, FIP Technology Forum Chair Vice-Dean, University of Helsinki, Finland
• Agnès Bobay-Madic. Pharmacist Centre Hospitalier Robert Bisson, Lisieux, France
• Paul Besnier, Pharmacy Intern, Centre Hospitalier Universitaire de Caen Normandie, France

This event will describe Development Goal 12: Pharmacy Intelligence and explore latest developments in data and intelligence that supports health care. It will identify practical approaches to progress towards Development Goal 12.

Aim:
To discuss development goal 12 and how to ensure it supports health care.

Learning objectives:
1. Define pharmacy intelligence and explain priorities for its development (FIP Development Goal 12)
2. Discuss approaches to community pharmacy data collection
3. Explain the METNA project and its approach to data collection and needs assessment
4. List the functions of the GPO Atlas
5. Analyse and comment on possible indicators for DG12

Moderator
Professor Robert Sindelar, Chair – One FIP Data and Intelligence Commission, Professor and Dean Emeritus, Faculty of Pharmaceutical Sciences, The University of British Columbia, Canada

Panelists and Speakers
- Christopher John, Lead for Data and Intelligence, FIP, UK

- António Rodrigues, Executive Director - Portuguese Association of Pharmacies, Portugal

- Farah Aqqad, Regional Engagement and Project Coordinator, FIP, Jordan

- Dr Mira Zugic, President of the Pharmaceutical Chamber of Montenegro

- Dr Tanniru Narayana/Dr Rao Vadlamudi – Indian Pharmaceutical Association

- Mr. Nurul Falah Eddy Pariang, President – Indonesian Pharmacists Association.

- Sherly Meilianti, Data and Intelligence Specialist, FIP, UK/Indonesia

This event will focus on intra and interprofessional alliances to ensure that we can work together to deliver the areas of policy addressed in this series. Panellists will also discuss working together with other agencies and policymakers to establish sustainable policies on vaccines access and equity, including how pharmacy can be a force of good in supporting vaccinations for all health workers.

About the programme:
Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access, and sustainability of vaccinations through policy development and implementation.

Moderator:
- Lina Bader - FIP Lead for Workforce Transformation & Development, Saudi Arabia 

Co-Moderator:
- Eduardo Savio – President of the Pharmaceutical Forum of the Americas, Uruguay

Panellists:
- Daphne Holt, Chair of Coalition for Life-course Immunisation, France

- Meghna Joshi-Von Heyden, Strategic Development Advisor, Commonwealth Pharmacists Association (CPA), Switzerland

- Suresh Bhojraj, Patron at Indian Association of Colleges of Pharmacy and Pro Chancellor at JSS Academy of Higher Education and Research, Mysuru, India

- Marleen Haems, Director of Professional Management, KOVAG / VAN, Belgium

- Katarina Milosevic Konstadinovic, Community Pharmacist, Chairman of Assembly of Pharmaceutical Chamber of Montenegro, Montenegro

Counterfeit, substandard and falsified medications and medical products endanger public health and FIP believes that pharmacists and pharmaceutical scientists should contribute to patient safety by actively participating in the fight against counterfeit, substandard, and falsified medicines.
Adapting and expanding on the theme of World Pharmacy Week (Pharmacy: Always trusted for your health), we would like to invite you to attend this webinar and learn more about the role of pharmacists in the emerging threat of counterfeit, falsified, and substandard medicines. The event has been sponsored by an unrestricted educational grant by Pfizer.

The expected outcomes of the event are:
1- to discuss the role of pharmacists in combating counterfeit, falsified, and substandard medicines.
2- to highlight various regional and global strengths, accomplishments, and success stories in the fight against counterfeit medications.
3- to identify emerging regional and global threats and challenges related to counterfeit medication.

Moderator:
- Lars-Åke Söderlund, President Swedish pharmaceutical society - Sweden 

Panellists:
- Catherine Duggan, CEO FIP, The Netherlands
- John Hertig, Vice-Chair and an Associate Professor of Pharmacy Practice, USA
- Manjiri Gharat, Vice-President, Indian Pharmaceutical Association, India
- Stephanie Kohl, Policy & Advocacy Officer, Belgium 
- Sally Galal, Associate Professor, Alexandria University, Egypt
- Dieudonne NZEYIMANA, Pharmacist and Sales Manager, Rwanda
- Renae Beardmore, Acting National President, Australia
- John Jackson, President, Western Pacific Pharmaceutical Forum, Australia  
- Pierre Souverain, Pfizer
- Caitriona Scott, Pfizer
- Gudrun Hubinger, Pfizer
- Zuzana Kusynová, Lead for Policy, Practice and Compliance, FIP, The Netherlands

Pharmacists are uniquely positioned to help communities and patients protect themselves from vector-borne diseases (VBDs). This webinar will describe the most prevalent VBDs in the European region and identify the most relevant roles that pharmacists can play in their prevention (including vector-control strategies and other measures), management and optimal treatment.

Learning objectives:
1. Describe the characteristics and epidemiology of the main VBDs in the European region;
2. Determine the roles that pharmacists can play in the prevention, detection, control and management of pharmacotherapy of VBDs; and
3. Identify the experiences developed by countries in Europe to support the actions of pharmacists in the fight against VBDs.

Moderator:
- Sari Westermarck, Community pharmacist, Finland

Panellists:
- Elkhan Gasimov, Technical Officer, Malaria, Neglected Tropical Diseases and other Vector-borne Diseases, World Health Organization Regional Office for Europe, Division of Country Health Programmes, Denmark

- Maria Dolores Bargues, Professor of Parasitology, University of Valencia and President of the Spanish Society of Tropical Medicine and International Health, University of Valencia, Spain

- Pınar Erkekoğlu, Head of Department of Toxicology, Hacettepe University Faculty of Pharmacy Department of Toxicology, Turkey

- Venelin Sapunarov, Chairman of the Board of the Regional Pharmaceutical College of Sofia, Bulgarian Pharmaceutical Union, Bulgaria

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

The expected outcomes of the event are:

1. Describe the FIP Development Goals and explain the components of DG 13 (and its three elements: workforce & education, science and practice).
2. Showcase the FIP tools, evidence, and resources to support DG 13 implementation across the three elements.
3. Identify priorities across practice, science, and workforce & education within DG 13
4. Discuss the importance monitoring and evaluation through data evidence and engage participants with FIP indicators development project

Moderator:
Catherine Duggan, CEO FIP, Netherlands

Panellists:
-Mahmoud Abdelrahman, President Egyptian Foundation of Clinical pharmacy EFCP, Egypt

- Paul Sinclair, Chair of the Board of Pharmaceutical Practice, FIP Australia

- Ramesh Walpola, Senior Lecturer School of Population Health, UNSW Sydney, Australia

-Virginia Olmos, Vice President AQFU, Uruguay

- Subhash Mandal, Vice President, Indian Pharmaceutical Association, India

- Ema Paulino, FIP Professional Secretar; Policy committee for statement on Women and RUM (Chair); General Manager, Ezfy, Portugal

- Eeva Teräsalmi, FIP Foundation Director Immediate Past Vice President of FIP, Finland

- Allie Jo Shipman, YPG Liaison to FIP Community Pharmacy Section; Director, National Alliance of State Pharmacy Associations, USA

- Luna Elbizri, Founder and Manager, Lunapharm Pharmacy, Lebanon

- Mary Ann Kliethermes, Director of Medication Safety and Quality, American Society of Health-System Pharmacists, USA

- Daragh Connolly, ExOfficio President, Irish Pharmacy Union, Ireland

- Certina Ho, Assistant Professor; Director, Educational Program Evaluation and Scholarship; Medication Safety Advisor, Department of Psychiatry; Leslie Dan Faculty of Pharmacy; University of Toronto; Institute for Safe Medication Practices Canada (ISMP Canada)

- Mariet Eksteen, Professional Development Officer, Pharmaceutical Society of South Africa (PSSA), South Africa

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

This programme is all about engaging the profession and supporting the profession to deliver in relevant and purposeful ways. By engaging our profession, members & colleagues everywhere with these relevant and applicable goals for the decade ahead, we can provide tools, monitoring and evaluation through data evidence, and identifying priorities across practice, science, and workforce & education.

Find out more about the FIP Development Goals here: www.fip.org/fip-development-goals

Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.

Learning objectives:
1. Provide insights of the therapeutic approaches and advancements used in the management of headaches.
2. Understand the role of non-prescription medicine as a tool in headache self-care
3. Identify the role of pharmacists in supporting the self-care of headache, through a regional lens.

Moderator:
-T.V. Narayana, President SEAR Pharm Forum, India

Panellists:
- Takuya Kumamoto, Professor Chair, FIP Special Interest Group on New Medicines, Hiroshima, Japan
- Luminita Constantin, Global Medical Lead CHC Pain, Sanofi, France
- Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology, King’s College (UK), United Kingdom
-Raj Vaidya, Community Pharmacist, Hindu Pharmacy, India

Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.

Learning objectives:
1. Provide insights of the therapeutic approaches and advancements used in the management of headaches.
2. Understand the role of non-prescription medicine as a tool in headache self-care
3. Identify the role of pharmacists in supporting the self-care of headache, through a regional lens.

Moderator:
- Nadia Al Mazrouei, Assistant Professor, Sharjah University, United Arab Emirates (UAE)

Panellists:
-Takuya Kumamoto, Professor, Chair, FIP Special Interest Group on New Medicines, Hiroshima, Japan
-Luminita Constantin, Global Medical Lead CHC Pain, Sanofi, France
-Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology, King’s College (UK)-United Kingdom
-Abdulaziz khaled Alkhaledi, Member of Executive Committee, Kuwait Pharmaceutical Association, Kuwait State

Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.

Learning objectives:1. Provide insights of the therapeutic approaches and advancements used in the management of headaches.
2. Understand the role of non-prescription medicine as a tool in headache self-care
3. Identify the role of pharmacists in supporting the self-care of headache, through a regional lens.

Moderator:
-Luis Lourenço, Professional Secretary, Community Pharmacy Section, Portugal

Panellists:
- Takuya Kumamoto, Professor Chair, FIP Special Interest Group on New Medicines, Hiroshima, Japan
- Luminita Constantin, Global Medical Lead CHC Pain, Sanofi, France
- Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology, King’s College (UK), United Kingdom
- Charlotte Verner Rossing, Vice-chair, FIP Special Interest Group on Pharmacy Practice Research FIP, Denmark

The Høst-Madsen Medal is the highest pharmaceutical science award of FIP and it is awarded every second years. The award is named after Danish pharmaceutical scientist and former FIP president Dr Erik Høst-Madsen and is made possible with the support of the Association of Danish Pharmacies (Danmarks Apotekerforening). This year we will present the award, during a digital event, to Prof. Hideyoshi Harashima, of Hokkaido University, Japan.

The event will start with short presentations on the nanomedicine/drug delivery theme from three young researchers from different countries, after which Prof. Harashima will provide some commentary. The event will continue with the president of FIP presenting the medal and certificate to Prof. Harashima, after which Prof. Harashima will give a lecture on “Multifunctional envelope-type nano devices: From controlled intracellular trafficking to clinical application for nanomedicines”.

Participants in the event will have the opportunity to send their messages and congratulations to Prof. Harashima via the Q&A box or chatbox in Zoom.

Moderator:
- Ross McKinnon, Chair of Board of Pharmaceutical Sciences, FIP - Australia

Panellists:
- Dominique Jordan, President FIP - The Netherlands
- Hideyoshi Harashima, Professor of Pharmaceutics and chair of Laboratory of Molecular Design of Pharmaceutics, Hokkaido University - Japan
- Dr Schultz, Research Associate, University of South Australia - Australia
- Dr Yamada, Associate Professor, Hakkaido University - Japan

All three domains of pharmacy; science, education, and practice are crucial for pharmacists to solidify and expand their role in various health systems. As early-career pharmacists, we sometimes lack professional direction and well-defined opportunities in our profession. FIP is actively involved in all aspects of pharmacy practice, pharmaceutical science, and education, mostly via the work of member associations and committed volunteers.

The purpose of this webinar is to introduce early career pharmacists and pharmaceutical scientists in Bahrain to the International Pharmaceutical Federation, the Young Pharmacy Group, and the FIP Development Goals.

Join us for an interactive session to discover more about how you, as a Bahraini pharmacist, can stand in solidarity with pharmacists all over the world to advance pharmacy. **The event is also open to pharmacy students.**

Moderators:
-Farah Aqqad, FIP Regional Engagement and Project Coordinator International Pharmaceutical Federation, Jordan
-Sherly Meilianti, FIP Data and Intelligence Specialist, International Pharmaceutical Federation, Indonesia

Facilitator:
-Abrar Husaini, Volunteer Pharmacist Al Shamil Field Hospital, Bahrain

Panellists:
-Lucas Ercolin, FIP YPG Chairperson of Public Relations, PUI Health Project Manager, FIP Young Pharmacists Group (YPG), Première Urgence Internationale (PUI), Brazil
- Ikwaibom Umoiyoho, FIP YPG Chairperson of Projects, Hospital Pharmacist Zenith Medical and Kidney Center, Nigeria
- Dalia Bajis, FIP Lead for Provision and Partnerships, International Pharmaceutical Federation, Bahrain
- Lina Bader, FIP Lead for Workforce Transformation & Development, International Pharmaceutical Federation, Saudi Arabia
- Abrar Husaini, Volunteer Pharmacist, Al Shamil Field Hospital, Bahrain

Support pharmacists to play an advisory role in community pain management with OTC analgesics.

The learning objectives of this symposia involves providing community pharmacists with:

- Consumer perspectives towards their pain management
- Importance of stratifying treatment based on patient underlying conditions & needs

This session will be chaired by Lars-Åke Söderlund, President of FIP Community Pharmacy Section, Sweden.

The expert panel involves

- Pamela Kushner, MD,FAAFP, USA
- Francesco Carlo Gamaleri, B.Pharm, FPS, Italy
- John Bell, B.Pharm, FPS Australia

Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.

Learning objectives:
1. Provide insights of the therapeutic approaches and advancements used in the management of headaches.
2. Understand the role of non-prescription medicine as a tool in headache self-care
3. Identify the role of pharmacists in supporting the self-care of headache, through a regional lens.

Moderator:
- Prosper Hiag, Member of the Council of the FIPm President African Pharmaceutical Forum (APF), Cameroon
Panellists:
-Takuya Kumamoto, Professor Chair, FIP Special Interest Group on New Medicines, Hiroshima, Japan
- Luminita Constantin, Global Medical Lead CHC Pain
Sanofi, France
- Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology King’s College (UK), United Kingdom
- Machi Hampango, Head Of Pharmacy Practice and Clinical Pharmacy, Faculty of Pharmacy, Nutrition and Dietetics, Lusaka Apex Medical University, Zambia

Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.
Learning objectives:
1. Provide insights of the therapeutic approaches and advancements used in the management of headaches.
2. Understand the role of non-prescription medicine as a tool in headache self-care
3. Identify the role of pharmacists in supporting the self-care of headache, through a regional lens.

Moderator:
-John Jackson, President Western Pacific Pharmaceutical Forum, Australia
Panellists:
-Takuya Kumamoto, Professor Chair, FIP Special Interest Group on New Medicines, Hiroshima, Japan
-Luminita Constantin, Global Medical Lead CHC Pain Sanofi, France
-Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology, King’s College (UK), United Kingdom
- Daniel Malone, Director of Pharmacy Education Monash University, Melbourne, Australia

Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.

Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.

Learning objectives:
1. Provide insights of the therapeutic approaches and advancements used in the management of headaches.
2. Understand the role of non-prescription medicine as a tool in headache self-care
3. Identify the role of pharmacists in supporting the self-care of headache, through a regional lens.

Moderator:
-Eduardo Savio, President Pharmaceutical Forum of the Americas, Uruguay

Panellists:
-Takuya Kumamoto, Professor Chair, FIP Special Interest Group on New Medicines, Hiroshima - Japan
- Luminita Constantin, Global Medical Lead CHC Pain Sanofi, France
- Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology King’s College (UK), United Kingdom
- Willington Montenegro, Manager Lider Pharmacy, Ecuador

he COVID-19 pandemic has had detrimental effects on healthcare professionals and in diverse ways including physically, mentally, socially, and financially. The new and unique challenges directly associated with the COVID-19 pandemic are exacerbating an already stressful work environment for pharmacists too. Pharmacists are reporting high level of stress and burnout in practice. Hence, there is an urgent need for pharmacists to be equipped with the knowledge, tools, and resources to cope and thrive in crises. This webinar aims to provide perspectives from research and practice on the impact of workplace burnout on pharmacist mental health and highlight evidence-based supportive mechanisms and prevention tools to improve the mental health and wellbeing.  

Learning objectives:
Describe the impact of the COVID-19 pandemic on pharmacists’ wellbeing using case studies from different countries.
Discuss potential strategies to address burnout among pharmacists.
Describe the gaps in mental health education in pharmacy education.
Learn about the role of pharmacists in suicide prevention in the community.

Moderator:
-Claire O’Reilly, Senior Lecturer School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Australia

Panellists:
-Sarira El-Den, Lecturer School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Australia
-Karlee Johnston, Associate Lecturer Pharmacology Australian National University, Australia
-Aiwen Wang, Principal Clinical Pharmacist, Lecturer Singapore General Hospital (SGH), Singapore. National University of Singapore (NUS), Singapore
-Lita Chew, Group Director (Allied Health) Singhealth, Singapore
-Hayley Gorton,Senior Lecturer in Pharmacy Practice University of Huddersfield, UK

Pharmacy teams are increasingly supporting patients with self-care. This webinar will focus particularly on appropriate management of choices of medicines and products to support women’s health, and the role of the pharmacist. A case study will be presented and the event will conclude with a panel discussion.

Aim:
To identify how the community pharmacy team can support self-care for women with common health problems.

Learning objectives:
1. Increase awareness of women’s health issues, how common they are, what impacts they have and how they can be managed;
2. Learn how to support women with their common health issues across their life course; and
3. Discuss appropriate management in the choice of medicines and products.

Moderator:
- Ema Paulino, FIP Professional Secretary, General Manager Ezfy, Portugal
Panellists:
- Nsovo Mayimele, Pharmacist Freelance, South Africa
- Gayle Anderson, Advanced Pharmacist Practitioner (Women's Health) Dr Gray's Hospital, Scotland, UK
- Safeera Hussainy, Adjunct Senior Lecturer Department of General Practice, Monash University, Australia

Pharmacy teams are increasingly supporting patients with self-care. This webinar will focus particularly on appropriate management of choices of medicines and products to support women’s health, and the role of the pharmacist. A case study will be presented and the event will conclude with a panel discussion.

Aim:
To identify how the community pharmacy team can support self-care for women with common health problems.

Learning objectives:
1. Increase awareness of women’s health issues, how common they are, what impacts they have and how they can be managed;
2. Learn how to support women with their common health issues across their life course; and
3. Discuss appropriate management in the choice of medicines and products.

Moderator:
- Ema Paulino, FIP Professional Secretary, General Manager Ezfy, Portugal
Panellists:
- Nsovo Mayimele, Pharmacist Freelance, South Africa
- Gayle Anderson, Advanced Pharmacist Practitioner (Women's Health) Dr Gray's Hospital, Scotland, UK
- Safeera Hussainy, Adjunct Senior Lecturer Department of General Practice, Monash University, Australia

Pharmacy teams are increasingly supporting patients with self-care. This webinar will focus particularly on appropriate management of choices of medicines and products to support women’s health, and the role of the pharmacist. A case study will be presented and the event will conclude with a panel discussion.

Aim:
To identify how the community pharmacy team can support self-care for women with common health problems.

Learning objectives:
1. Increase awareness of women’s health issues, how common they are, what impacts they have and how they can be managed;
2. Learn how to support women with their common health issues across their life course; and
3. Discuss appropriate management in the choice of medicines and products.

Moderator:
- Ema Paulino, FIP Professional Secretary, General Manager Ezfy, Portugal
Panellists:
- Nsovo Mayimele, Pharmacist Freelance, South Africa
- Gayle Anderson, Advanced Pharmacist Practitioner (Women's Health) Dr Gray's Hospital, Scotland, UK
- Safeera Hussainy, Adjunct Senior Lecturer Department of General Practice, Monash University, Australia

Pharmacy teams are increasingly supporting patients with self-care. This webinar will focus particularly on appropriate management of choices of medicines and products to support women’s health, and the role of the pharmacist. A case study will be presented and the event will conclude with a panel discussion.

Aim:
To identify how the community pharmacy team can support self-care for women with common health problems.

Learning objectives:
1. Increase awareness of women’s health issues, how common they are, what impacts they have and how they can be managed;
2. Learn how to support women with their common health issues across their life course; and
3. Discuss appropriate management in the choice of medicines and products.

Moderator:
- Ema Paulino, FIP Professional Secretary, General Manager Ezfy, Portugal
Panellists:
- Nsovo Mayimele, Pharmacist Freelance, South Africa
- Gayle Anderson, Advanced Pharmacist Practitioner (Women's Health) Dr Gray's Hospital, Scotland, UK
- Safeera Hussainy, Adjunct Senior Lecturer Department of General Practice, Monash University, Australia

Pharmacy teams are increasingly supporting patients with self-care. This webinar will focus particularly on appropriate management of choices of medicines and products to support women’s health, and the role of the pharmacist. A case study will be presented and the event will conclude with a panel discussion.

Aim:
To identify how the community pharmacy team can support self-care for women with common health problems.

Learning objectives:
1. Increase awareness of women’s health issues, how common they are, what impacts they have and how they can be managed;
2. Learn how to support women with their common health issues across their life course; and
3. Discuss appropriate management in the choice of medicines and products.

Moderator:
- Ema Paulino, FIP Professional Secretary, General Manager Ezfy, Portugal
Panellists:
- Nsovo Mayimele, Pharmacist Freelance, South Africa
- Gayle Anderson, Advanced Pharmacist Practitioner (Women's Health) Dr Gray's Hospital, Scotland, UK
- Safeera Hussainy, Adjunct Senior Lecturer Department of General Practice, Monash University, Australia

La reticencia a las vacunas fue considerada como una de las 10 principales amenazas para la salud mundial en 2019 por la OMS. La reticencia es uno de los principales factores que impactan en la tasa de cobertura vacunal. La información veraz y rigurosa es una herramienta crucial para combatir la actual infodemia a la que nos enfrentamos. La comunicación directa con los pacientes es una oportunidad clave para que los farmacéuticos desbloqueen los posibles temores a las vacunas y proporcionen mensajes claros y basados en la evidencia para apoyar la adopción de las vacunas. En este evento se presentan estrategias basadas en la evidencia para desarrollar intervenciones dirigidas por los farmacéuticos que se centran en la comunicación con los pacientes con el fin de fomentar la confianza en las vacunas y mejorar su aceptación.

Objetivos de aprendizaje

- Comprender los temores sobre las vacunas a nivel individual

- Discutir posibles herramientas para los farmacéuticos en la construcción de una conversación efectiva .

- Comprender los esfuerzos concretos en las farmacias comunitarias para la promoción de la vacunación a través de estrategias de comunicación eficaces

The World Health Organization has listed vaccine hesitancy — concerns related to vaccination or outright refusal to receive vaccines despite availability — as one of the top 10 threats to global health in 2019. This threat is evidenced by recent outbreaks of vaccine-preventable diseases in many high-income countries and the sheer volume of disinformation circulating regarding the recently approved vaccines against COVID-19.

Often “one-size-fits-all” vaccine promotion efforts can backfire when they are presented to individuals who are already sceptical of vaccines. This event will outline evidence-based strategies for developing pharmacist-led interventions which focus on communication with patients in order to build vaccine confidence and improve uptake.

This event will be offred in Eglish with live translation in Spanish and French. 

Learning Objectives:
Understanding vaccine hesitancy and common reasons behind hesitancy; and
Building effective conversation through evidence-based tools.

Moderator:
-Boyan Todorov, President of the FIP Health and Medicines Information Section, President of the FIP Health and Medicines Information Section FIP, Switzerland
Panellists:
- Helen Petousis-Harris, Associate Professor and Vaccinologist University of Auckland, New Zealand
- Amy Chan, Global Lead – Workforce Transformation, Senior Clinical Research Fellow, and Lead of the Academic Practice Unit, University of Auckland, and Auckland District Health Board, New Zealand
- Rosario Cáceres, Community pharmacist, vaccines expert and vaccine confidence advocate, Royal Pharmaceutical College of Seville and Andalusian Council of Pharmacists, Spain

L'Organisation mondiale de la Santé a classé l'hésitation vaccinale parmi les 10 principales menaces pour la santé mondiale en 2019. Les récentes épidémies de maladies évitables par la vaccination dans de nombreux pays à revenus élevés et l’ampleur de la désinformation au sujet des vaccins récemment approuvés contre la COVID-19 témoignent de cette menace. La réticence est l'un des principaux facteurs qui influent sur les taux de couverture vaccinale. Une information véridique et rigoureuse est un outil essentiel pour lutter contre l'infodémie actuelle à laquelle nous sommes confrontés. La communication directe avec les patients est une occasion clé pour les pharmaciens de révéler les craintes potentielles liées aux vaccins et de fournir des messages clairs, fondés sur des preuves, pour soutenir l'adoption des vaccins. Cet événement présente des stratégies fondées sur des données probantes pour développer des interventions dirigées par des pharmaciens et axées sur la communication avec les patients afin de renforcer la confiance dans les vaccins et d'améliorer leur utilisation.

Objectifs d'apprentissage

- Comprendre les craintes que suscitent les vaccins au niveau individuel.

- Discutez des outils possibles pour les pharmaciens afin d'établir une conversation efficace.

- Comprendre les efforts concrets des pharmacies communautaires pour promouvoir la vaccination par des stratégies de communication efficaces.

There is an evolving role for community pharmacists, not only in reactive respiratory illness, but also in supporting proactive individual and community respiratory wellness. However, what needs to change in terms of policy and regulation for these roles to become part of mainstream pharmacy practice? This symposium will mark the United Nations' International Day of Clean Air for Blue Skies, by addressing the drivers and barriers for the full deployment of these services, and discuss the key points of the FIP call to action on this global health priority.

learning objectives:
- Identify prevailing barriers limiting the deployment of services to reduce the impact of air pollution by community pharmacists.
- Describe facilitators and enablers that can influence air pollution service delivery by community pharmacists.
- Understand the policy and regulatory landscape that needs to be established to promote air pollution mitigation services by community pharmacists.

Moderator:
- Lars-Åke Söderlund, President, Community Pharmacy Section FIP, Sweden

Panellists:
-Ema Paulino, Professional Secretary FIP, Portugal 
-Paul Sinclair, Chair of the Board of Pharmaceutical Practice FIP, Australia
-Deana Lykins, Policy & Government Affairs Consultant The Clean Breathing Institute, USA
-Anna Murphy, Consultant Respiratory Pharmacist
University Hospitals of Leicester NHS Trust, United Kingdom
-Job F.M. van Boven, Chair of the Dutch Respiratory Pharmacists Group, Royal Dutch Pharmacist Association (KNMP), The Netherlands

Pain is a common symptom of a range of conditions or situations, and can manifest and be experienced with different intensities, from mild discomfort to highly incapacitating. Supporting patients in adequately managing pain and using medicines to alleviate it in an optimal way is a common and important part of pharmacists’ daily practice.

A particular type of pain that often leads to consultations to pharmacists and the use of self-care medicines is headache. Contemporary lifestyles and ways of working – especially at such challenging times as we are experiencing in many parts of the world, with lockdowns and confinements – lead to increased stress, increased use of technology and screen time, and often a lack of good sleep, which all frequently lead to headaches.

Relieving headaches and regaining mental clarity are important for patient wellbeing and productivity, and pharmacists can play a role in advising on the most appropriate strategies and therapeutic approaches that are suitable for each patient.

Learning Objectives:
1. Provide an understanding of 21st century headaches and their impact on patient health and wellbeing.
2. Highlight patients’ expectations from pharmacists in addressing headaches.
3. Demonstrate the role that pharmacists can play in enabling self-care of headaches.

Moderator:
- Prof. Parisa Aslani, FIP Vice President - Australia

Panellist:
- Peter Goadsby, Director of NIHR Clinical Research Facility & Professor of Neurology, King’s College (UK) - United Kingdom
- Kerrie Smyres, writer and patient advocate, “The Daily Headache” - USA
- Ema Paulino, FIP Professional Secretary - Portugal

A fájdalom számos betegség tünete lehet, intenzitása pedig az enyhe kényelmetlenséget okozó panasztól a munkaképtelenséghez vezető fájdalomérzetig terjedhet. A betegek segítése a fájdalom megfelelő enyhítésében fontos gyógyszerészi feladat.

Fejfájás esetén a betegek gyakran fordulnak tanácsért a gyógyszerészekhez és nem ritkán vény nélkül kapható szereket alkalmaznak az öngyógyszerelés részeként. A modern életmód és munkakörülmények - különösen a Covid-19-járvánnyal kapcsolatos lezárások kapcsán - fokozott stresszhez, a képernyők előtt eltöltött idő növekedéséhez, az alvásminőség romlásához, és végső soron gyakran fejfájáshoz vezetnek.

A fejfájás enyhítése és a munkaképesség visszanyerése fontos a betegek jóléte szempontjából, és a gyógyszerészeknek fontos szerepe van az ennek elérését szolgáló stratégiákkal és kezelési lehetőségekkel kapcsolatos tanácsadásban.

A webinárium céljai:

1. A 21. századi fejfájás és a betegek egészségére és jólétére gyakorolt hatásainak bemutatása

2. A betegek gyógyszerészekkel kapcsolatos elvárásainak bemutatása a fejfájás kezelésével kapcsolatban

3. A gyógyszerészek szerepének bemutatása a fejfájással kapcsolatos öngondoskodásban

Self-care can empower consumers by giving them the knowledge and tools to improve the quality of their daily lives. For example, consumers often treat minor symptoms, such as a mild headache or a cold, themselves using products purchased over-the-counter at a local pharmacy or grocery store.

In 1998, a special working group of the World Health Organization (WHO) offered an inclusive definition of self-care: “Self-care in health refers to the activities individuals, families and communities undertake with the intention of enhancing health, preventing disease, limiting illness, and restoring health. These activities are derived from knowledge and skills from the pool of both professional and lay experience. They are undertaken by lay people on their own behalf, either separately or in participative collaboration with professionals.”

In today’s rapidly changing healthcare environment, self-care should be recognised as an integral element of a coordinated and comprehensive national health policy.

Self-care is a lifelong habit and culture that includes:

• Actions by individuals to stay healthy and take care of minor and long-term conditions;
• Making healthy lifestyle choices;
• Using medicines (both prescription and non-prescription) responsibly; and
• Recognising symptoms — and assessing and addressing these, if necessary, in partnership with a healthcare professional (not necessarily a doctor).

Moderator:
- Ema Paulino, FIP Professional Secretary, General Manager Ezfy, Portugal
Panellists:
- Austen El-Osta, Director, Self-Care Academic Research Unit (SCARU) Imperial College London, UK
- Donna Castle, Executive Director of Policy and Communications, PAGB, the consumer healthcare association, UK
- Bidhata Khatri, FIP Health and Medicines Information Section Secretary, India

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

This programme is all about engaging the profession and supporting the profession to deliver in relevant and purposeful ways. By engaging our profession, members & colleagues everywhere with these relevant and applicable goals for the decade ahead, we can provide tools, monitoring and evaluation through data evidence, and identifying priorities across practice, science, and workforce & education.

Find out more about the FIP Development Goals here: www.fip.org/fip-development-goals

Moderator:
- Andreia Bruno-Tomé, Global Lead for DG 5 - Competency Development, Senior Consultant
Independent, Portugal

Panellists:
- Ian Coombes, Member FIPED, Director of Pharmacy, Royal Brisbane and Women’s Hospital, Queensland, + School of Pharmacy, University of Queensland, Australia
- Asmaa Al-Haqan, DG2 Lead / WDH, Clinical Instructor, Kuwait University - Kuwait
- Franciscus Cahyo KRISTIANTO, WDH-DG2 Lead, Lecturer, University of Surabaya, Indonesia
- Belma Pehlivanović, YPG FIP Liaison / FIP WiSE Remote Volunteer, Teaching and Researching Assistant
Faculty of Pharmacy University of Sarajevo, Bosnia and Herzegovina
- Anisha Sandhu, Assistant Lecturer School of Pharmacy, Monash University Malaysia, Malaysia

Opioids have been successfully utilised in the management of pain. However, when not managed adequately, there is a risk they may lead to addiction and abuse among patients, with dramatic consequences in clinical and social terms. One consequence of this is the rise in cases of opioid-related overdose and deaths experienced in several countries. As medicine experts and an essential part of the healthcare team, pharmacists can support in addressing the overuse of opioids. This webinar aims to outline how pharmacists can optimise opioid use for improved patient outcomes.


Learning objectives
 At the end of the webinar, participants will:
1. Describe how pharmacists can enable the responsible use of opioid analgesics for chronic pain management
2. Identify opioid stewardship practices that can be adopted by pharmacists in the hospital settings
3. Explain the role that pharmacists can play in addressing the opioids overuse crisis
4. Recognize how pharmacists can contribute to opioid deprescribing and inappropriate pain relief

Moderator:
- Parisa Aslani, Co-chair of the working group on Patient Safety, University of Sydney, Australia

Panellists:
- Paul Glare, Chair of Pain Medicine and Director of the Pain Management Research Institute (PMRI) Northern Clinical School, School of Medicine, Faculty of Medicine & Health, University of Sydney, Australia
- Jonathan Penm, Assistant Secretary, Hospital Pharmacy Section FIP, Australia
- Sri Suryawati, Head, Division of Clinical Pharmacology and Medicine Policy, Department of Pharmacology and Therapeutics, Faculty of Medicine, Public Health and Nursing, Gadjah Mada University. Indonesia - Yogyakarta
- Daniel Zlott, PharmD, BCOP Senior Vice President, Education & Business Development American Pharmacists Association, United States

Reconsidering your career or trapped in a job you hate? Often one is faced with a choice to change career paths and find more satisfaction and meaning in your work.
However, in moments of burnout and dissatisfaction at work, the grass often looks greener on the other side. But is it? Career change is a decision that should be made with sobriety. This digital event will provide the details on strategies for successfully switching from one area of practice to a different one of interest, while addressing difficulties that often arise when young pharmacists seek to explore new career paths.

Learning outcomes:
By the end of the webinar, participants will be able.
1. To identify and analyze one’s reasons for career change.
2. To identify and select the right career henceforth.
3. To identify one’s skills and compatibilities in the career choice made.
4. To identify one’s interests and how they affect career choices
5. To identify one’s values and how they affect career change
6. Renumeration and its impact on career decisions.

Moderator:
- Anisha Sandhu, Assistant Lecturer, Monash University - Malaysia

Co-Moderator:
- Otuto Amarauche CHUKWU, Co-founder/Research Lead, Medchain Solutions - Nigeria

Panellists:
- Brian Cicali, Vice-Chair of New Generation of Pharmaceutical Sciences (NGPS) SIG; Ruffolo Graduate Education and Research Fellow, University of Florida, College of Pharmacy - USA
- Jass Liew, Head of Medical & Technical Affairs, ASEAN and ANZ, P&G Health, Regional lead, Vitamins, Minerals and Supplements, AMA, Procter & Gamble - Malaysia
- Phaik Yeong Cheah, Head of Bioethics & Engagement, Mahidol Oxford Tropical Medicine Research Unit, University of Oxford - Thailand and UK

This event is for hospital and health-system pharmacists and leaders to review best practices for advanced and specialist pharmacist development in the hospital setting. Content will include information about the European Association of Hospital Pharmacists (EAHP) Position Paper on Hospital Pharmacy Specialisation and the FIP Hospital Pharmacy Section Basel Statements in relation to the future of clinical pharmacy practice.

Learning objectives:
a. Have an increased awareness of the competencies required of a hospital pharmacist
b. Understand global initiatives in progression and recognition pathways for advanced practice and specialisation
c. Identify resources available for use of the FIP HPS Basel Statements in the hospital pharmacy advanced practice
d. Identify new competencies that hospital pharmacists will need in the future

Moderator:
- Lina Bader, FIP Lead for Workforce Transformation and Development, Saudi Arabia

Panellists:
- András Süle, EAHP President & Chief Pharmacist at the Péterfy Hospital – National Institute of Traumatology in Budapest Hungary, European Association of Hospital Pharmacists (EAHP), Hungary (home country), Belgium (country in which EAHP is based in)
- Kirstie Galbraith, Associate Director, Workforce Development Hub, Global Lead, Advanced and Speciality practice (DG4), Workforce Development Hub, Director, Experiential Development and Graduate Education, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University - Australia
- Josep Maria Guiu Segura, Vice-president Euro, Hospital Pharmacy Section, International Pharmaceutical Federation, Director of Pharmacy and Medicines, Consortium of Health and Social Care of Catalonia - Spain

For students and early career pharmacists or pharmaceutical scientists, it can be difficult to know where to find support and guidance when considering professional development and career trajectory.

This FIP YPG webinar seeks to introduce young pharmacists and pharmaceutical scientists to both the Young Pharmacists’ Group and the International Pharmaceutical Students’ Federation as professional organizations that can offer many benefits to their members.

The learning outcomes include:
1. Attendees will gain insights about the organizational structure of FIP, YPG, and IPSF.
2. Learn about networking and volunteer opportunities of these organizations.
3. Learn about the benefits of membership in these organizations.
4. Hear first-hand accounts of how membership in these organizations has impacted members.

Chair:
- Louisa Sullivan, Clinical Pharmacist, University of Washington Medical Center - USA

Co-moderator:
- João Guedes, IPSF President 2020 - 2021, International Pharmaceutical Students’ Federation (IPSF) - Portugal

Panellists:
- Renly Lim, Research Fellow, University of South Australia - Australia
- Ikwaibom Umoiyoho, Hospital Pharmacist, Zenith Medical and Kidney Center - Nigeria
- Safiye Çağansel, Pharmacist In Charge, Treasurer & FIP Liaison, Safiye Çağansel Eczanesi, Cyprus Turkish Pharmacists’ Association - Cyprus
- Oussama MADADI, IPSF President-Elect 2020 - 2021, International Pharmaceutical Students’ Federation (IPSF) - Algeria
- Karima BENNARA, Chairperson of Pharmacy Education 20-21, International Pharmaceutical Students’ Federation (IPSF) - Algeria

This event will have a focus on the issues around health literacy and access to information. The societal influences on the ‘’infodemic’’ will be laid out, also the role of health care professionals, health workers and be vaccine hesitant people. We will consider all the policy elements that need to be addressed to overcome this, identifying tools to overcome these issues from a range of angles and the role pharmacy can play.

About the programme – FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November. Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access and sustainability of vaccinations through policy development and implementation.

This event will be moderated by Professor Timothy Chen, President of the Social and Administrative Pharmacy Section at FIP and the Head of Pharmacy Practice and Health Services Research at The University of Sydney.

Moderator:
Timothy F Chen, Head of Pharmacy Practice and Health Services Research, The University of Sydney

Speakers:
• Mujahidhussein G Valji - Chief Pharmacist, Aga Khan Health Services, Tanzania
• Dr. Régis Vaillancourt - Pharmacy Consultant, Canada
• Dr. Fiona Stanaway - Senior Lecturer in Clinical Epidemiology, School of Public Health, University of Health, Australia
• Hannelie Meyer - Professor in the School of Pharmacy, Sefako Makgatho Health Sciences University, and Head of the South African Vaccination and Immunisation Centre (SAVIC)

Watch the recording the first day here. 

This event  explores FIP Development Goal’s role in pharmacy practice transformation globally.  It will identify practical strategies and WHO roles and challenges in vaccines transformational globally and how to help community pharmacists to improve their medication-related problems in community pharmacies.

Learning objectives:

1. To know the role of accreditation in education transformation 

2. Describe the educational transformational challenges in many countries in EMRO region such as KSA and Lebanon 

3. Describe approaches to establish inter-professional Education and practice 

4. Tele-pharmacy the new emerging opportunity to improve pharmacists role in patient care 

During this two days event we’ll explore transformation of pharmacy practice toward patient care during COVID-19 pandemic 

This event will also explore FIP Development Goal’s role in pharmacy practice transformation globally.  It will identify practical strategies and WHO roles and challenges in vaccines transformational globally and how to help community pharmacists to improve their medication-related problems in community pharmacies.

Learning objectives:

1. To know the role of accreditation in education transformation 

2. Describe the educational transformational challenges in many countries in EMRO region such as KSA and Lebanon 

3. Describe approaches to establish inter-professional Education and practice 

4. Tele-pharmacy the new emerging opportunity to improve pharmacists role in patient care 

More info here. 

With the publication of the document FIP Vector-Borne Diseases: A Handbook for Pharmacists, produced in collaboration with the Pharmaceutical Forum of the Americas (PFA), the International Pharmaceutical Federation (FIP) offers an overview of these pathologies and notes that pharmacists are uniquely positioned to help communities and patients protect themselves from them. This webinar will describe the most prevalent vector-borne diseases in the Southeast Asian region; subsequently, the pharmaceutical interventions that this professional can carry out will be identified and finally the experiences developed by the SEAR Pham Forum regarding the pharmaceutical approach to Vector Borne diseases will be presented.

1) Recognize the main concepts related to vector-borne diseases.
2) Describe the characteristics and morbidity and mortality of the main vector-borne diseases in the region of the Southeast Asia.
3) Determine the activities that the pharmacist can develop from the pharmacy for the prevention, detection, control, and management of pharmacotherapy of vector-borne diseases.
4) Identify the experiences developed by the SEAR Pham Forum to support the actions of pharmacists in the fight against diseases transmitted by vectors

Moderator:
-T.V. Narayana, President, SEAR Pharm Forum, President Indian Pharmaceutical Association - India
Facilitator:
-Manisha Shridhar, Regional Advisor, IPR, Trade&Health, WHO-SEARO - India

Speakers:
- Manjiri Gharat, FIP Vice-President, Vice-President of Indian Pharmaceutical Association (IPA) and Chairperson of IPA Comm.Ph.Division; Executive Committee Member, SEARPharm Forum of FIP and WHO; Principal K. M. Kundnani Pharmacy - India
- Chinta Abayawardana, FIP Members Organization/ Individual Member, General Secretary Pharmaceutical Society of Sri Lanka - Sri Lanka
- David C. Yohanes, Clinical Pharmacist Clinical pharmacist in Bandung Hospital - Indonesia
- Yagya Prasad Neupane, Ex-Chairmen Nepal Pharmacy Council -Nepal

Episode 11 of the FIP Development Goals Digital Programme is focused on “advancing integrated services”. The goal visualizes a people-centred and integrated health care provision that is based on an interprofessional and cross-setting seamless continuum including pharmacist-delivered professional services. Through the lenses of pharmaceutical sciences, workforce, education, and practice, this event aims to advance the ideals of integrated service delivery in a way that benefits our patients and lead to improvement of health outcomes.

Event outcomes:
1. Describe and explain the components of FIP DG 7 (and its three elements: workforce & education, science and practice).
2. Showcase the FIP tools, evidence, and resources to support DG 7 implementation across the three elements.
3. Identify priorities across practice, science, and workforce & education within DG 7
4. Engage our members in an activity to support monitoring and evaluation of the Goal through data evidence

Moderator:
- Mariet Eksteen, Global Lead for Advancing Integrated Services (DG 7) FIP - South Africa

Panellists:
- Bob Buckham, National Programme Manager – Integrated Community Pharmacy Services Central Technical Advisory Services (TAS) - New Zealand
- Bärbel Holbein, FIP Global Lead for DG7 Advancing integrated services Lecturer, University of Bremen -
Germany
- Lars-Åke Söderlund, President, the Community Pharmacy Section, FIP Co-chair, the FIP Congress Programme Committee International Pharmaceutical Federation - Sweden
- Jacqueline Surugue, Chair of the FIP Pharmaceutical Technology Forum, Hospital Pharmacist, Centre Hospitalier Georges Renon - France

Health systems and health care professionals are called upon to address and mitigate the impact of air pollution on people’s health and quality of life. There is an evolving role for community pharmacists, not only in reactive respiratory illness, but also in supporting proactive individual and community respiratory wellness. This webinar will provide examples of services that pharmacists can deliver to support better breathing.

Learning objectives:
- Describe the role that pharmacists can play in mitigating air pollution in the community.
- Identify the different tools available to pharmacists to enable the reduction of the impact of air pollution in the community.
- Understand the various arrays of services that community pharmacists can employ in supporting better breathing.

Modetaror:
- Lars-Åke Söderlund, President, Community Pharmacy Section, FIP - Sweden

Panellists:
- Daniella Munene, CEO Pharmaceutical Society of Kenya - Kenya
- Job F.M. van Boven, Chair of the Dutch Respiratory Pharmacists Group, Royal Dutch Pharmacist Association - The Netherlands
- Emilio Santoro, Medical Affairs Principal Scientist, Respiratory and Skin Health, Global Category, GSK Research & Development - United Kingdom

This event will explore latest developments in digital health that supports self-care. It will identify practical strategies to appraise latest technology and manage misinformation and the ‘infodemic’.  Current practice and role of the pharmacist in digital health is also discussed.

Aim: To discuss digital health and how to ensure it supports safe and effective self-care

Learning objectives:

1. Define digital health and explain digital health priorities (FIP Development Goal 20)

2. List ways digital health can enable self-care

3. Describe approaches to delivering safe and effective digital self-care

4. Give examples of current pharmacy practice in digital health that supports self-care

Moderator

- Jaime Acosta-Gómez, Community Pharmacist and pharmacy owner, Farmacia Acosta, Spain

Panellists:

- Timothy Aungst, Associate Professor.  Freelance Writer and Consultant, The Digital Apothecary, USA

- Peter Guthrey, Senior Pharmacist, Strategic Policy, Pharmaceutical Society of Australia, Australia

- Jan De Belie, Professional Affairs Advisor, Pharmaceutical Group of the European Union, Belgium 

Episode 3 examines inequities in gender access to vaccines to inform pharmacy policy. Various angles to vaccinations and the gender will be discussed including general gender access, terms of empowering women as caregivers to support vaccinations, the impact of COVID-19 on gender inequity, and the issues around gender inequity in the workforce (which is especially important to discuss in 2020 Year of the Health Worker).

The “Role of Early Career Pharmaceutical Organisation (ECPO) in Global Health” report describes the activities related to global health undertaken by individuals and groups of pharmacists and pharmaceutical scientists from different countries. The launch event will showcase key findings from the “Global survey on the role of Early Career Pharmaceutical Organisation (ECPO) in global health”, discuss the role that youth can play in global health citing examples from different national YPGs, and discuss opportunities to advocate on the role of ECPO in global health across regions.

Learning objectives:
1. learn about the key findings from the Global survey on the role of Early Career Pharmaceutical Organisation (ECPO) in global health
2. hear from national YPG representatives from different regions about the global health-related activities they are doing in their region.
3. be able to identify areas of development in global health and opportunities to advocate for early career pharmacists and pharmaceutical scientists in their regions.

Moderator:
- Raquel Oliveira - Portugal

Panellists:
- Sherly Meilianti - Indonesia
- Lucas Ercolin - Brazil
- Deanna Mill - Australia
- Onyeka Obidiegwu - Nigeria
- Funmbi Okoya - Nigeria/US
- Renly Lim - Australia
- Anggun P Wardhani - Indonesia
- Cedric Chua Chairman - Malaysia
- Teoh Cherh Yun - Malaysia

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021.

The focus of the 10th episode in our webinar series on the FIP Development Goals is FIP DG4 (Advanced & specialist development) and the need to have a flexible, capable and competent pharmacy workforce to meet the needs of complex pharmaceutical care. Join us on 4 August at 11:00 CEST. 

Learning objectives:
1. Describe and explain the components of FIP DG 10 (and its three elements: workforce & education, science and practice).
2. Showcase the FIP tools, evidence, and resources to support DG 4 implementation across the three elements.
3. Identify priorities across practice, science, and workforce & education within DG 4
4. Engage our members in an activity to support monitoring and evaluation of the Goal through data evidence

Moderators:
-Desak Ernawati, FIP Global Lead for DG4 Advanced and specialist development, Academic & researcher Universitas Udayana-Indonesia
-Arit Udoh, FIP Global Lead for DG4 Advanced and specialist development, Senior Clinical Trial CRD/Project Manager University of Birmingham, UK

Panellists:
- Kirstie Galbraith, Assoc. Director, Workforce Development Hub; Director, Experiential Development and Graduate Education, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University- Australia
- Sylvain Grenier, MEPS President, Director, Plasma Proteins and Related Products Formulary, Canadian Blood Services - Canada
- Marilyn Morris, FIP Board of Pharmaceutical Sciences ExCo and Expert Member, SUNY Distinguished Professor, State University of New York at Buffalo, USA

Diabetic foot is a devasting complication of diabetes that can lead to loss of a limb and life. It has a complex pathology characterised by neuropathy, ischaemia and slow healing. Often the resulting loss in feeling leaves patients unable to sense the damage to their feet. 451 Million suffer with diabetes worldwide, 1 in 10 will get a foot ulcer, 80% go to have an amputation, 8 out of 10 amputations can be prevented by intervention.

Aim: is to strengthen the link of Foot Health and Diabetes and to create an interest and commitment to regular foot care for every diabetic prescription dispensed to the patient.

Target audience: Healthcare professionals – particularly the pharmacy team, who support people to self-care.

Learning Objectives:

• To describe how the pharmacy team can support self-care of feet for people with diabetes;
• Identify and educate pharmacists on regular foot checks and foot care routines 3.Discuss approaches on empowering people and pharmacists on what to ask the people with diabetes, when to refer to a specialist or GP and what to recommend as a treatment.

Programme

• Welcome (5 minutes) – Raj Vaidya, Moderator
• Supporting people with diabetes to look after their feet – pathology and common conditions (20 minutes) – Maria Mendes, National Association of Pharmacies (ANF) TBC
• The potential role of the Pharmacists in footcare of people with diabetes – footchecks and footcare routines (20 minutes) – Astrid Czock, Qualiccare
• Case study: footcare in diabetes management (20 minutes) – Luna El Bizri, Lunapharm Pharmacy
• Panel discussion – questions and answers (20 minutes) – Panel + Moderator
• Summary and close (5 minutes)- Raj Vaidya, Moderator

The World Health Organization lists vaccine hesitancy—concerns related to vaccination or outright refusal to receive vaccines despite availability—as one of the top ten threats to global health in 2019. This threat is evidenced by recent outbreaks of vaccine preventable diseases in many high-income countries and the sheer volume of disinformation circulating regarding the recently approved vaccines against novel Sars-Cov-2 virus.

Often times, “one-size-fits-all” vaccine promotion efforts can backfire when presented to individuals who are already sceptical of vaccines. This event will outline evidenced-based strategies for developing pharmacy-led immunization campaigns which communicate the value of vaccines to specific patient groups in order to build vaccine confidence and improve uptake.

Delivered in English with live translation in French and Spanish languages. 

Learning Objectives:
1. Understanding vaccine hesitancy and common reasons behind hesitancy
2. Developing a robust immunization campaign: steps and essential components
3. Assessing the success of immunization campaigns and importance of continuing advocacy

Moderator:
- Amy Chan, Senior Clinical Research Fellow, and Lead of the Academic Practice Unit
University of Auckland, and Auckland District Health Board - New Zealand

Panellists:
- Jane Barratt, Secretary General, International Federation on Ageing - Canada
- Gary Finnegan, Editor, Vaccines Today - Ireland
- Velisha Perumal-Pillay, Senior lecturer, University of KwaZulu-Natal - South Africa

Moderator:
- Amy Chan, Senior Clinical Research Fellow, and Lead of the Academic Practice Unit
University of Auckland, and Auckland District Health Board - New Zealand

Panellists:
- Jane Barratt, Secretary General, International Federation on Ageing - Canada
- Gary Finnegan, Editor, Vaccines Today - Ireland
- Velisha Perumal-Pillay, Senior lecturer, University of KwaZulu-Natal - South Africa

Moderator:
- Amy Chan, Senior Clinical Research Fellow, and Lead of the Academic Practice Unit
University of Auckland, and Auckland District Health Board - New Zealand

Panellists:
- Jane Barratt, Secretary General, International Federation on Ageing - Canada
- Gary Finnegan, Editor, Vaccines Today - Ireland
- Velisha Perumal-Pillay, Senior lecturer, University of KwaZulu-Natal - South Africa

This event will explore the evolution in our understanding of health literacy and identify practical strategies to improve health literacy in community populations.  The role of the pharmacist in health literacy is also discussed.

Health literacy describes the skills that enable individuals to obtain, understand and use information to make decisions and take actions that have an impact on health.   Several countries now have well established national strategies and plans to improve health literacy through programs to improve the skills of patients and the public, and service changes to reduce the literacy demands on patients and the public.

Aim: To discuss health literacy, how it readies the global population for self-care and how pharmacists can contribute

Learning objectives:

• Define health literacy.
• Describe different rates of health literacy around the world.
• Discuss challenges and opportunities for improving health literacy;
• Critique the role of the pharmacist in health literacy.

Programme

1. Welcome (5 minutes) – Dr Sarah Dineen-Griffin, Charles Sturt University (Moderator)
2. Importance of health literacy and how health systems can support it: a pharmacy perspective (20 minutes) – Helen Ryan, National Adult Literacy Agency (Ireland).
3. Improving health literacy (20 minutes) – Dr Anandi Law, Western University of Health Sciences (USA)
4. The role of pharmacists in supporting health literacy (20 minutes) – Greg Duncan, Monash University (Australia).
5. Panel Discussion (20 minutes) – Panel + Moderator
6. Summary and close (5 minutes) - Dr Sarah Dineen-Griffin, Charles Sturt University (Moderator)

Pharmacists are uniquely positioned to help communities and patients protect themselves from vector-borne diseases (VBDs). This webinar will describe the most prevalent VBDs in the Western Pacific region and identify the most relevant roles that pharmacists can play in their prevention (including vector-control strategies and other measures), management and optimal treatment.

1) Identify the most prevalent vector-borne diseases in the Western Pacific region.

2) Describe the characteristics and morbidity and mortality of the main vector-borne diseases in the region.

3) Identify the most relevant roles that pharmacists can play in their prevention (including vector-control strategies and other measures), management and optimal treatment

Moderator:
John Jackson, President, Western Pacific Pharmaceutical Forum

Panellists:
- Aya Yajima, NTD focal point, Malaria and Neglected Tropical Diseases Unit, WHO Regional Office for the Western Pacific
- James Kelly, Malaria Focal Point, WHO WPRO
- Renly Lim, Research Fellow, University of South Australia, FIP YPG President
- Judilynn Solidum, Professor, University of the Philippines College of Pharmacy

Participantes:

- Santos Nicolau (Bastonário da Ordem dos Farmacêuticos de Angola);

- Elisabete Jacinto (Membro do Policy Statement Working Group da FIP sobre o papel do farmacêutico nas doenças não transmissíveis);

- Leonel Almeida (Coordenador de Assistência Farmacêutica da Secretaria Municipal de Saúde de Porto Alegre, Brasil);

- Elisabete Barros (Coordenadora do Programa Nacional de Luta contra as Doenças Não Transmissíveis, São Tome e Príncipe).

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. Starting in March, the 21 digital events aim to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

This programme is all about engaging the profession and supporting the profession to deliver in relevant and purposeful ways. By engaging our profession, members & colleagues everywhere with these relevant and applicable goals for the decade ahead, we can provide tools, monitoring and evaluation through data evidence, and identifying priorities across practice, science, and workforce & education.

Find out more about the FIP Development Goals here: www.fip.org/fip-development-goals

he choice of delivery device or container closure system versus the Reference Listed Drug is a key consideration when developing a biosimilar. Can a biosimilar be developed using a different container closure system than the reference Listed Drug and if yes, how different can this container
closure system be? If the reference is in a vial or a prefilled syringe, can the biosimilar be in an autoinjector? What are additional requirements that need to be considered in order to be able to claim interchangeability.

Learning objectives:
1. we focus on requirements applicable to biosimilars when targeting the US or the EU markets.
2. we discuss acceptable differences in device-component between a biosimilar and the
reference product.
3. we address a few case studies.

Moderator:
- Mathew Cherian, Consultant - USA

Co - Moderator:
- Kaushik Desai, Advisor , Indian Pharma Machinery Manufacturers Association - India

Panellist:
- Alison Bascou, Senior Regulatory Affairs Manager, Becton- Dickinson - France

Early career Pharmacists and Pharmaceutical Scientists have to uphold professionalism by participating in sessions and workshops that offer training/certification. This webinar seeks to enlighten young pharmacists and pharmaceutical scientists on ways to develop their skills and participate in trainings that offer certification for their chosen career paths. 

Asthma affects up to 1 in 10 people globally. Living well with asthma depends on avoiding triggers and using good, safe medicines in the right way at the right time. However, there is currently much sub-optimal use of medicine that can result in waste and harm including avoidable hospital attendances and admissions. Hospital pharmacists can be an important part of the asthma pathway and powerful change agents. This webinar will provide updates on major changes in international guidelines that highlight asthma is an inflammatory condition and for safety no-one over 12 should be treated with a short-acting beta-agonist (SABA) alone without inhaled corticosteroids. You will hear from experts from the Asthma Right Care social movement about how to make impactful change happen in the provision of asthma care within secondary care settings.

By the end of this webinar participants will have:
1. Received a critical update on international asthma guidelines and the implications for hospital pharmacists
2. Learnt about tools available to start a conversation with patients and prescribers about Asthma Right Care including how to address over-reliance on SABA and acute care and how to use the right medicines in the right way
3. Discussed what leadership opportunities, motivation and capabilities are needed to bring about change such as improved discharge from emergency departments and respiratory wards; and shared approaches between hospital and community pharmacists.

Chair:
- Ema Paulino, Professional Secretary, FIP - Portugal
Panellist:
- Marina García-Pardo, Family physician, IbSalut, Mallorca - Spain
- Toby Capstick, Consultant Pharmacist - Respiratory Pharmacist, Leeds Teaching Hospitals NHS Trust - United Kingdom

This Pharmacy Technician Symposium is the 3rd in a series and focuses on Pharmacy Technician regulations in the context of practice, education, continuing professional development and organizations. Four Pharmacy Technicians will share their experience

Learning objectives:
1. Review recent trends in regulations that enable better patient access to care
2. Provide a quick review of literature on the topic of Pharmacy technician regulation, related to practice, education, continuing professional development and organizations
3. Understand how regulations have impacted a diverse set of global markets
4. Share global case studies of how pharmacy technician regulation positively impacts patient care in practice
5. Identify best practices in regulatory advancement that support the pharmacy technician profession preparing for the decade ahead

Moderator:
- Vijay Sarma, VP–Expert Audience Marketing, McCann Health - Canada
Co-Moderator:
- Abigail Tan Ming Li (KKH), Pharmacy Technician, KK Women's and Children's Emergency Pharmacy - Singapore

Panellists:
- Jennifer Falkenrath, Bureau Manager, Division of Occupational and Professional Licensing in the State of Utah - United States of America
- Cristiano Matos, Pharmacy Technician, Farmácia Coimbra - Portugal
- Sakhumhlanga Goci, Pharmacy Technician, Eastern Cape Department of health, Cecilia Makiwane hospital mdantsane - South Africa
- Peter Karegwa Mwangi, National Chairman, Kenya National Union of Pharmaceutical Technologists - Kenya

Many jurisdictions around the world have implemented Apology Legislation and non-punitive medication error reporting requirements in order to create transparency, learning and prevention to enhance patient confidence and patient safety in the healthcare system and work towards creating a Just Culture or a Culture of Safety in health professionals and practice sites.   This webinar will present the value and the experiences of jurisdictions, which have enacted legislation and additional standards of care, for community pharmacy practice. Spread and scale of learning through international collaboration exemplified by the international medical regulatory authority will also be presented.

The attendee will learn:

1)      The importance sections of the FIP #4757 (Pharmacists Role in Medication without Harm) and Culture of Safety.

2)      The value of Apology Legislation on medication error resolution, transparency and patient confidence.

3)      The value of centralized medication error reporting in community pharmacy practice to enhance patient safety, quality assurance and prevent errors.

4)      The importance of international collaboration for the evolution to “Just Culture” and supportive legislation.

Moderator:
- Ronald Guse, FIP Regulators Forum Chair, NABP - Canada

Speakers:
- Prof. Aslani Parisa, University of Sydney - Australia
- Jan Byrd, Director, Health Policy Healthcare Excellence - Canada
- Mitul Jadeja, Vigilance and Risk Management of Medicines (VRMM) Division, Medicines and Healthcare products Regulatory Agency, MHRA - UK
- Alison Reid Executive Director, International Association of Medical Regulatory Authorities (IAMRA) - Australia
- Andi Shirtcliffe, Chief Advisor - Pharmacy, Office of the Chief Medical Officer, Ministry of Health - New Zealand

This event aims to provide different perspectives on how the pandemic has impacted the scope of services provided by pharmacists in the community, hospital and clinical biology settings. In this roundtable discussion, a panel of experts in different areas will share their thoughts in which services were suspended or de-prioritised and need to be recovered or restored, and which new services emerged and may need to preserved beyond the pandemic.

Learning objectives:
1. Understand the impact of the pandemic on the scope of services pharmacists provide in the different settings
2. Discuss the priorities in the restoration or recuperation of services among different regions

Moderator:
- Robert Moss, President, Hospital Pharmacy Section, FIP - The Netherlands

Co - Moderators:
- Lars-Åke Söderlund, President, Community Pharmacy Section, FIP - Sweden
- Julien Fonsart, President, FIP Clinical Biology Section, FIP - France

Panellist:
- Esteban Zavaleta, Director of Pharmacy, Hospital Clínica Bíblica - Costa Rica
- Ana Paula Martins, President, Portuguese Pharmaceutical Society - Portugal
- Ismael Olmos, Head of the Pharmacy Department, Member of the Clinical Pharmacology Unit, Hospital Vilardebó - Uruguay
- Mariet Eksteen, Professional Development and Support, Pharmaceutical Society of South Africa (PSSA) - South Africa
- András Süle, EAHP President & Chief Pharmacist at the Péterfy Hospital – National Institute of Traumatology in Budapest Hungary, European Association of Hospital Pharmacists (EAHP)
Hungary (home country) | Belgium (country in which EAHP is based in)
- Amrahi Buang, President, Malaysian Pharmacists Society (MPS) - Malaysia
- Chris Freeman, National President, Pharmaceutical Society of Australia - Australia
- Ziad Nassour, Former President of the Lebanese Order of Pharmacists, Lebanese Order of Pharmacists - Lebanon

A Direct Application of the FIP Basel Statements on Human Resources, Training and Development & Aligned with FIP Development Goals.

Both the FIP Development Goals and the Hospital Pharmacy Section Basel Statements list the competency of the pharmacy workforce as important. In a listing of priority goals from the DG and the BS, FIP members identify competency goals as a top priority. The HPS Vice Presidents also list competency as a high priority for advancing hospital pharmacy practice. The webinar will address curricula and ongoing continuing education to provide students and practitioners with the necessary knowledge and skills for contemporary hospital pharmacy services.

Moderator:
- Marianne F. Ivey, Professor Emerita, Pharmacy Practice and Administrative Sciences, University of Cincinnati - USA

Panellist:
- Daniel Kibuule, Associate Dean, - Hage Geingob Campus, University of Namibia - Namibia
- Salwa Ahsan, Chief of Pharmacy, Shifa International Hospitals Ltd., H-8/4, Islamabad - Pakistan

Episode 2 takes a life-course approach to discussing vaccination. The panelists will focus on age and explore vaccines equity and access through life’s ages and stages – from childhood (including pregnancy) to later adulthood – from a pharmacy perspective. They will focus on setting out the policy issues and immediate next steps, determining what pharmacy needs to do to singularly affect the most change in this area.

About the programme – FIP’s 2021 digital programme to Transform Vaccination Globally, Regionally, & Nationally comprises 2 series, totaling 12 events running between June and November. Building on the outcomes of the 2020 programme, the 2021 FIP digital programme focuses on supporting FIP members in accelerating equity, access and sustainability of vaccinations through policy development and implementation.

About this series – The first of the two series comprises 5 episodes which include the opening event alongside 4 other events which explore equity in vaccinations across the different angles of age, gender, literacy & education, and interprofessional unity & collaboration.

Moderator:
- Lina Bader, FIP Lead for Workforce Transformation and Development, FIP

Guest:
- Jane Barratt, Secretary-General International Federation on Ageing

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021.

Episode 8 of the FIP Development Goals Digital Programme has as a focus – people-centred care. The goal visualizes collaborative interprofessional strategies and people-centred professional services to support the prevention, screening, clinical management, and therapeutic optimisation of non-communicable diseases (NCDs) and long-terms conditions (LTCs). Hence, the event will seek to amplify how pharmaceutical education, workforce, practice and sciences can be integrated to ensure pharmacists’ contribution to the prevention and management of NCDs.

Learning objectives:
1. Describe and explain the components of FIP DG 15 (and its three elements: workforce & education, science and practice).
2. Showcase the FIP tools, evidence, and resources to support DG 15 implementation across the three elements.
3. Identify priorities across practice, science, and workforce & education within DG 15
4. Engage our members in an activity to support monitoring and evaluation of the Goal through data evidence

Moderator:
- Gonçalo Sousa Pinto, Lead for Practice Development and Transformation, FIP - Spain

Panellists:
- Astrid Czock, CEO, QualiCCare - Switzerland
- Tolulope Osigbesan, Advocacy and Partnerships Officer, NCDs Alliance - Switzerland
- Aniekan Ekpenyong, Practice Transformation Projects, Coordinator, FIP - Nigeria
- Isabel Jacinto, Executive Director, Graduate School of Health and Management (EPGSG), National Association of Pharmacies (ANF) - Portugal
- Yu-Chieh (Jack) Chen, Secretary General, Taiwan Society of Health-System Pharmacists - Chaina Taiwan

As the global population continues to age, pharmacists' role in long term care and retirement homes will become increasingly more crucial. During the COVID-19 pandemic, with older persons being particularly vulnerable to the most severe forms of the disease, and often isolated from their families and loved ones, the care provided by long-term care facilities became all the more important to preserve health and well-being and prevent disease. This also raised the need to discuss the future role that pharmacists may play in supporting care and medication management in these facilities and to this particular population group.

1) Understanding the role that pharmacists play in medicine optimisation and reduction of medication-related harm in long-term care facilities
2) Understand the impact of the pandemic on the role of the pharmacists in long-term care
3) Discuss multidisciplinary synergies in the context of long-term care facilities
4) Identify changes in organisational culture of reducing psychotropic prescribing in long-term care facilities

Moderator:
-Robert Moss, President Hospital Pharmacy Section of the International Federation of Pharmacists, The Netherlands

Panellists:
- Tim Chen, President FIP Social and Administrative Pharmacy Section, Australia
- Anisa Shivji, Founder and CEO, RxVisit and Long term care expert, Canada
- Hui-Chen Su, Director Taiwan Society of Health-System Pharmacists (TSHP), China Taiwan
- Mouna Sawan, Researcher Centre for Medicine Use and Safety, Monash University Research Fellow, Australia

Asthma affects up to 1 in 10 people globally. Living well with asthma depends on avoiding triggers and using good, safe medicines in the right way at the right time. However, there is currently much sub-optimal use of medicine. Community pharmacy can be an important part of the asthma pathway and powerful change agents. This webinar will update on major changes in international guidelines that highlight asthma is an inflammatory condition and for safety no-one over 12 should be treated with a short-acting beta-agonist (SABA) alone without inhaled corticosteroids. You will hear from community pharmacists in the Asthma Right Care social movement about how to have impactful conversations about personal, national and international change and how to make it happen.


By the end of this webinar participants will have:
-Received a critical update on international asthma guidelines and the implications for pharmacists
-Learnt about tools available to start a conversation with patients and prescribers about Asthma Right Care including how to address over-reliance on SABA and how to use the right medicines in the right way
-Discussed what opportunities, motivation and capabilities are needed to bring about change.

Moderator:
- Ema Paulino, General Manager Ezfy, Portugal

Panellists:
- Francesc Moranta Ribas, Community Pharmacist, Farmacia Sanz Guiilén, Spain
-Darush Attar-Zadeh, Respiratory Lead Pharmacist, Community Pharmacy Locum Independent Prescriber, Cross Chemist North Central London Clinical Commissioning Group, UK
-Debbie Rigby, Director, Pharmeducation Clinical Associate Professor, Queensland University of Technology, Brisbane, Australia

The “FIP UNITWIN Pathfinder Toolkit” is a step-by-step guide to support the global expansion of the FIP-UNESCO UNITWIN programme. It will also support academic institutions across Africa to establish an Africa-wide association of schools of pharmacy, with the leadership of African Pharmaceutical Forum and building on the experiences of similar associations around the world.

At the end of this session, participants will:

1. Learn about the FIP-UNESCO UNITWIN Programme and the value of educational partnerships
2. Share expressions of interest to join new FIP-UNESCO UNITWIN centres for excellence at their regions
3. Discuss the way forward for the establishment of an African-wide association of schools of pharmacy

Moderators:
-Ralph Altiere, Dean and Prof. University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, USA
-Prosper Hiag, President African Pharmaceutical Forum,
Cameroon

Panellists:
-Nilhan Uzman, FIP UNITWIN Programme Lead, FIP Lead for Education Policy and Implementation, The Netherlands
- Anne H Anderson, Vice Chair UK National Commission for UNESCO, UK
- Alison Ubong Etukakpan, FIP Educational Partnerships Coordinator, Nigeria
-Wanda Maldonado, Dean & Representative University of Puerto Rico & COIFFA, Puerto Rico, USA
-Cyril Usifoh, Prof. and former Dean University of Benin, Nigeria
- Yahya E. Choonara, Prof. and Head of the Dep. of Pharmacy and Pharmacology, University of the Witwatersrand, South Africa
-Chiluba Mwila, Lecturer & Research University of Zambia, Zambia
-Gisèle Étamé, Head of Department of Pharmaceutical Sciences University of Douala, Cameroon
- Aysu Selcuk, Lecturer Ankara University, Turkey
- Khalid Garba Mohammed, Lecturer Bayero University, Nigeria
-Arinola E. Joda, Head of Clinical Pharmacy and Biopharmacy Department, University of Lagos, Nigeria
-Reda Djidjik, President & Prof. Algerian Federation of Pharmacy, Algeria

Aim:
To identify how the community pharmacy team can support self-care for people with musculoskeletal pain

Learning objectives:
1. List the signs and symptoms of musculoskeletal pain;
2. Describe how to support people with musculoskeletal pain
3. Discuss appropriate management in the choice of medicines.

Moderator:
- Luis Lourenço, FIP Professional Secretary, Community Pharmacy Section, Portugal

Panellists:
- Laura Murphy, Pharmacy Clinical Leader and Clinical, University Health Network - Canada
- Philip Conaghan Director of the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, - UK
- Hilary McKee, Consultant Pharmacist Northern Health and Social Care Trust, UK

Participantes

- Ema Paulino , Membro do Comité Executivo/ Secretária Profissional da FIP

- Eduardo Tavares, Presidente da Entidade Reguladora Independente da Saúde (ERIS)

- Artur Nhanengue, Diretor dos Serviços Farmacêuticos do Hospital Central de Maputo (HCM) Moderador Santos Nicolau, Bastonário da Ordem dos Farmacêuticos de Angola

Vaccination coverage rates for several diseases are suboptimal and remain below WHO targets in many countries of all income levels. As such, FIP considers that it is essential to promote dialogue and understanding around these perceptions among healthcare professionals’ organisations at the international level, so that these can be cascaded to the regional, country and local levels.
After this webinar the participants should have a better understanding of the following topics:
1. The role of the various health professions in contributing to increased vaccination coverage
2. Drivers and barriers to diversifying vaccination pathways and providers.
3. Possible actions by the different health professions in addressing vaccine hesitancy and complacency.
4. Collaboration and autonomy of the various healthcare professionals in delivering vaccinations.

Moderator:
Jane Barratt, Secretary-General International Federation on Ageing

Panellists:
-David O. Barbe, President World Medical Association
-Howard Catton, Chief Executive Officer International Council of Nurses
- Jonathon Kruger, CEO World Physiotherapy
- Catherine Duggan, CEO International Pharmaceutical Federation (FIP)
- Enzo Bondioni, Executive Director, FDI World Dental Federation

This workshop aims at providing an overview on current trends in medication adherence research. Methos for assessing medication adherence are described. The evidence on interventions for managing medication adherence is reviewed. Finally, innovative approaches in this field of research are discussed. 

The FIP Pharmacy Practice Research SIG (PPR SIG) was created with the main scope of increasing pharmacy practice contributions to global health through the provision of greater access to the latest high-quality international pharmacy practice research. The PPR SIG also aims to cultivate an international forum for the dissemination of quality, international pharmacy practice research for all stakeholders and stimulate communication, discussion, networking, and collaboration between international pharmacy practice stakeholders.

Based on this objective, this PPR virtual summer meeting aims to increase the quality and quantity of pharmacy practice research by exchanging and disseminating information at an international level. New networks and collaborations will be established on major themes for experienced researchers and higher degree students. 

This workshop aims at presenting the state-of-art of systematic reviews and meta-analyses in the biomedical field. An overview of the main changes of the new PRISMA statement (2020) compared to the previous version (2009) is provided. Our role as researchers and healthcare professionals in enhancing science reliability is also discussed.

This webinar will present selected findings from a recent FIP survey on the regulation of the distribution of medicines and pharmacists’ role in supporting responsible self-care. It will also focus on the role of pharmacies in relation to the use of generics, as well as alternative and complementary medicines.

Learning objectives:
1: Awareness of the importance of the community pharmacists’ role in self-care
2: Identify key aspects of the pharmacist’s action in empowering patients for self care
3: Demonstrate possible positions of the pharmacist in the recommendation of alternative and complementary medicines

Moderator:
- Ronald Guse, Chair, FIP Regulators Forum- USA/Canada

Facilitator:
- Rúben Viegas, FIP Practice Development Projects Coordinator - Spain

Panellists:
- Gonçalo Sousa Pinto, FIP Lead for Practice Development and Transformation - Spain
- Sarah Dineen-Griffin, Lecturer in health services management and leadership, Charles Sturt University - Australia
- Magaly Rodríguez de Bittner, PharmD, FAPhA, FNAP, Associate Dean of Clinical Services and Practice Transformation and Vice-President Forum of the Americas, University of Maryland School of Pharmacy - USA
- Benjamin K. Botwe, President, Pharmaceutical Society of Ghana - Ghana

Pharmacists are uniquely positioned to help communities and patients protect themselves from vector-borne diseases (VBDs). This webinar will describe the most prevalent VBDs in the Eastern Mediterranean region, and identify the most relevant roles that pharmacists can play in their prevention (including vector-control strategies and other measures), management and optimal treatment.

Learning objectives:
1) Identify the most prevalent vector-borne diseases in the Eastern Mediterranean region.
2) Describe the characteristics and morbidity and mortality of the main vector-borne diseases in the region.
3) Identify the most relevant roles that pharmacists can play in their prevention (including vector-control strategies and other measures), management and optimal treatment

Moderators:
- Nadia Al Mazrouei, Assistant Professor, Sharjah University - United Arab Emirates (UAE)
- Wael Ali, President, President Egyptian organization of pharmacy. (EOP) - Egypt

Panellists:
- Rula Darwish, Professor, University of Jordan, Jordan
- Sherif Kamal, Director of pharmaceutical services, Children’s Cancer Hospital- Egypt
- Nidhal Marie, Prof Dr in the School of Pharmacy, Almustansirya University-Iraq - Iraq
- Yousif Adam Ahmed Sabeel, Director, Planning and Policy Department, National Medical Supplies Fund - Sudan

Episode 1, the digital programme’s Opening Event, will set the stage for the entire programme. Together we will revisit the key outcomes of the Transforming Vaccination 2020 programme, specifically focusing on the outcomes relating to shaping policy around equity, access and sustainability and how they are shaping the FIP vaccination agenda for 2021. We will also describe this year’s programme, outline its key aims and objectives as well as outcomes. This special programme opener is for anyone invested in transforming and shaping vaccination in pharmacy!

Moderators:
- Lina Bader, Lead for Workforce Transformation & Development, International Pharmaceutical Federation -Saudi Arabia
- Farah Aqqad, Regional Engagement and Project Coordinator International Pharmaceutical Federation (FIP) - Jordan

Panellists:
- Catherine Duggan, CEO International Pharmaceutical Federation (FIP) - The Netherlands
- Gonçalo Sousa Pinto, Lead for Practice Development and Transformation International Pharmaceutical
Federation (FIP) - Spain
- G. Sumalatha, Executive Committee Member SEARPharm Forum - India
- Prosper Hiag, President African Pharmaceutical Forum (APF) - Cameroon
- John Jackson, President Western Pacific Pharmaceutical Forum - Australia
- Nadia Al Mazrouei, President EMROPharm Forum, Academic &Healthcare consultant - UAE

This event will showcase current self-care delivery in community pharmacy across the globe and explore how future delivery could look. People centred care is at the heart of self-care and so this is an important area to explore including the associated communication skills. Strategies to build trust and rapport is vital to self-care will also be discussed. This topic is important because pharmacy teams are increasingly supporting patients with self-care.

Aim:
Explain current and future practice with delivering people centred self-care.

Learning objectives:
1. Summarise current practice of self-care delivery;
2. Propose future practice of self-care delivery;
3. Define people centred care;
4. List the communication skills required for people-centred care;
5. Discuss how to build trust and rapport to deliver self-care.

Moderator:
Sari Westermarck, Proprietary Pharmacist (Finland)

Speakers:
Alistair Bursey, New Brunswick College of Pharmacists, Canada.
David Skinner, President, International Self-care Foundation
Parisa Aslani, Professor of Medicines Use Optimisation, University of Sydney, Australia.
Betty Chaar, Associate Professor, University of Sydney, Australia

Webinar promovido pela AFPLP - FIP/YPG - APJF com as participações de:

- Catarina Nobre (Associação Portuguesa de Jovens Farmacêuticos)

- Filipa Ferreira (Secção Jovem da Federação Internacional Farmacêutica)

- Jorge Batista (Associação de Farmacêuticos dos Países de Língua Portuguesa)

Air pollution needs to be addressed urgently and not only as an environmental and ecological threat, but also as a direct threat to health. This webinar will describe the multiple ways in which air pollution can be harmful to health. Understanding such impacts is essential so that professional services and interventions by pharmacists can be developed to address this global threat.

Learning objectives:
- Identify the various ways that outdoor and indoor air pollution impacts on human health
- Understand the short-term and long-term impact of air pollution on health
- Illustrate how air pollution might change the type of professional services offered by pharmacists
- Describe the different roles pharmacists can play in addressing air pollution

Moderator:
Prof. Rula Darwish, University of Jordan - Jordan

Panellists:
Prof. Gary WK Wong, Professor and honorary consultant, Department of Paediatrics Chinese University of Hong Kong - Hong Kong
Prof. Fan Chung, Professor of Respiratory Medicine, National Heart & Lung Institute, Imperial College - UK

The FIP YPG mentorship programme which is currently on the first cycle aims to provide guidance for young pharmacists and pharmaceutical scientists who are developing their career.
The webinar will focus on educating young pharmacists and pharmaceutical scientists on how to effectively utilize the GROW model as a way to develop their skills and expertise in mentorship and it is an excerpt from the career development toolkit for early career pharmacists and pharmaceutical scientists. There will also be a panel session where the participants will have the opportunity to interact with panelists; the panel will include the main speaker, two mentors and two mentees. The aim of the Panel session is to provide participants with practical examples of how mentorship works and provide feedback on the current FIP YPG mentorship cycle.

The learning outcomes for the webinar include:
· Participants will be introduced to the FIP YPG mentorship program.
· Participants will learn about the GROW model and how it can be effectively linked to mentorship.
· Participants will get feedback and real-life testimonials from mentors and mentees in the ongoing cycle of the FIP YPG mentorship programme.
· Participants will also gain insights on the important attributes to consider for, when selecting mentors in their desired area of practice.

Moderator:
- Benjamin Wong, Lead Digital Health Record Analyst, Government ACT - Australia
Main speaker:
- Margarita Gutierrez, Assistant Professor 5, University of the Philippines- Manila College of Pharmacy - Philippines
Panellists:
- Charlotte Verner Rossing, Director of Research and Development at Pharmakon, The Danish College of Pharmacy practice - Denmark
- Miranda Sertić, Ass. Professor, University of Zagreb Faculty of Pharmacy and Biochemistry - Croatia
- Aulia Hanifah Fadlol, Business Development at GoApotik, PT. Global Urban Esensial / University of Indonesia - Indonesia
- Emine Merve Yıldırım, Pharmacy Student - Turkey

The FIP Development Goals Digital Programme “Setting goals for the decade ahead” is a comprehensive online event series providing coverage of the 21 goals over 21 events in 2021. The programme aims to provide description, direction and context for each specific goal, with a global plan for the decade ahead and how each nation, within each region can identify and prioritise which goals are the priorities and how the goals can support developments and transformation for them.

FIP Development Goal 21 “Sustainability in pharmacy” is not only about ensuring sustainable services in practice and all that this encompasses, but also covers the impact of pharmacy and pharmaceuticals on the environment. In this event, we explore sustainability in pharmacy from the perspectives of workforce & education, science, as well as practice – and we will showcase the strategies, tools and resources of FIP on this Goal. The event features a global panel of pharmacy experts and is co-chaired by FIP CEO Dr Catherine Duggan.

Event outcomes:
1. Describe the FIP Development Goals and explain the components of DG 21 (and its three elements: workforce & education, science, and practice)

2.Showcase the FIP tools, evidence, and resources to support DG 21 implementation across the three elements.

3. Identify priorities across practice, science, and workforce & education within DG 21

4. Engage our members in an activity to support monitoring and evaluation of the Goal through data evidence

Moderator:
Catherine Duggan, CEO - FIP, The Netherlands
Co-moderator:
Lina Bader, FIP Lead for Workforce Transformation & Development, Saudi Arabia

Panelists':
Eeva Teräsalmi, FIP Vice President, Finland
Susan James, Director of quality at Ontario College of Pharmacists, Canada
Saja Alnahar, Assistant Professor Yarmouk University - Jordan
Eduardo Savio, President Pharmaceutical Forum of the Americas, Uruguay
Manjiri Gharat, Vice-President Indian Pharmaceutical Association, India